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ABSTRACT

MODULATION OF CARDIAC Kv CURRENTS BY Kvβ2 AND PYRIDINE
NUCLEOTIDES
Peter Joseph Kilfoil
April 6, 2016
Myocardial voltage-gated potassium (Kv) channels regulate the resting
membrane potential and the repolarization phase of the action potential. Members
of the Kv1 and Kv4 family associate with ancillary subunits, such as the Kvβ
proteins, that modify channel kinetics, gating and trafficking.

Previous

investigation into the function of cardiac β subunits demonstrated that Kvβ1
regulates Ito and IK,slow currents in the heart, but the role of Kvβ2 in the myocardium
remains unknown. In heterologous expression systems, Kvβ2 increases surface
expression of Kv1 channels, shifts the activation potential of Kv1 channels to more
polarized voltages, and increases the inactivation of Kv1 channels. Accordingly,
the electrophysiological phenotype in Kvβ2-/- mice was examined to uncover its
role.
To investigate the effects of the loss of Kvβ2 on cardiac repolarization, we
performed whole-cell electrophysiology on primary cardiac myocytes. We found
Kv current density was reduced and action potential duration prolonged in
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myocytes lacking Kvβ2. To isolate the molecular interactions by which Kvβ2 was
affecting Kv currents, we show that Kvβ2 co-immunoprecipitates with Kv1.4 and
Kv1.5 in heart lysates. To measure if surface expression of these Kv channels
was reduced with the loss of Kvβ2, we performed immunofluorescent confocal
microscopy of isolated cardiac myocytes. We found that the surface expression
of Kv1.5 was reduced in Kvβ2-/- myocytes. We also performed a membrane
fractionation technique to demonstrate that the proportion of total cellular Kv1.5 at
the membrane was reduced in Kvβ2-/-. Together, these findings support our
hypothesis that Kvβ2 plays a role in the generation of functional Kv currents in the
myocardium by interacting with members of the Kv family.
The pyridine nucleotides, NAD[P](H), are ubiquitous cofactors utilized as
electron donors and acceptors by over 250 cellular oxidoreductases. Work out of
our laboratory has shown that the Kvβ proteins are functional enzymes of the aldoketo reductase family, that utilize NAD[P]H to catalyze the reduction of substrates.
Furthermore, follow up work has shown that the redox status of bound pyridine
nucleotide (PN) modifies the gating of Kvα-Kvβ channel complexes in
heterologous expression systems. To examine a physiological role for PN in
cardiac repolarization, whole-cell and single channel cardiac myocyte currents
were recorded under the exposure to various PN redox states. We found that the
inactivation rates and open probabilities of Kv currents in isolated myocytes are
sensitive to the redox status of PN, and that surface action potentials in an isolated
heart model are prolonged by treatment with factors that increase intracellular
NADH concentration.
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CHAPTER I
BACKGROUND
The ability to maintain and utilize ionic gradients across a semipermeable
membrane is one of the defining characteristics of life on this planet. It has been
long believed that life on Earth originated in the sea as single-celled
microorganisms that have acquired increasing complexity over the ages. In time,
the protocell somehow acquired the ability to maintain a high K +/low Na+ cytoplasm
while bathed in the high Na+ of the oceans. It should be noted that an alternative
theory, in which the primordial cell developed terrestrially, has recently been
proposed.1 In this new paradigm, evidence is presented supporting the argument
that the birthplace of the first cell was in vapor-rich vents in inland geothermal
systems. There are two main driving evidences behind this hypothesis. First, the
protocell would not have yet acquired the molecular machinery (i.e. active transport
via energy dependent transmembrane pumps) to maintain a high intracellular K+
concentration in low [K+] seawater, implying that, initially, these cells’ cytoplasm
was of similar composition to that of the aqueous environment from which they
arose. Second, cells across all three domains, archaea, bacteria, and eukarya,
utilize trace elements such as zinc, manganese and phosphate in a variety of
conserved cellular processes. Seawater is low in Mn2+ and Zn2+, the latter being
found at concentrations in the picomolar to femtomolar range.2 Analysis of the
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composition of geothermal pools shows these inorganics to more closely match
that of the cytoplasm.1
While the origin of the primordial cell may be debated, it is evident that the
increasing complexity of life has mirrored its ability to asymmetrically distribute
inorganic ions (and later, organic molecules) across its semipermeable
membranes, and more importantly, to utilize this gradient as a form of potential
energy. The evolution of selectively permeable ion channels and transporters is
key to higher forms of life.
In the animal kingdom, maintenance of the steady-state ratio of K+/Na+
across the cell membrane via the sodium-potassium-ATPase accounts for up to
4% of total energy expenditure in the myocardium 3 and up to 20% in neurons.4
Furthermore, myocardial Ca2+-ATPase (SERCA) utilizes up to 30% of cellular
energy reserves.5

The appropriation of energy to maintaining various ionic

gradients underscores their critical importance.
Eurkaryotic cells have the capacity to synthesize ATP by utilizing a proton
gradient generated across the inner mitochondrial membrane, i.e. aerobic
respiration. One of the key evolutionary differences separating prokarya from
eukarya is the presence of membrane-enclosed organelles, such as the
mitochondria, and subsequently the ability to increase the efficiency of ATP
conversion from energetic substrates.
Aside from the universally conserved usage of the mitochondrial proton
gradient to produce cellular energy (ATP), various specialized cell types utilize the
electrochemical gradient generated by other asymmetrical ionic distributions to

2

perform unique functions. Most cells maintain a negative cytoplasmic resting
membrane potential relative to their surroundings, which is generated by three
main processes: the Gibbs-Donnan equilibrium, the activity of the Na-K-ATPase
pump, and the summation of chord conductances of ions to which the membrane
is permeable, i.e. Na+, K+, and Cl-.
The Gibbs-Donnan equilibrium states that the majority of intracellular
membrane-impermeant ions have a negative charge at physiological pH, such as
proteins, organic polyphosphates, amino acids and nucleic acids. Since these
species cannot reach a chemical equilibrium across the membrane, they impart a
net negative charge to the cytoplasm. These anions contribute approximately -10
mV to the resting membrane potential relative to the extracellular fluid.
Excitable cells, such as neurons and myocytes, maintain a much more
hyperpolarized resting membrane potential than other cell types, typically in the
range of -40 to -90 mV. The majority of this potential results from gradients of
various inorganic ion concentrations across the plasma membrane. Cytoplasmic
concentrations of K+ (~150 mM), Na+ (~10 mM), and Cl- (5 mM) differ considerably
from those typically found in the extracellular solution, K+ (5mM), Na+ (145 mM),
Cl- (120 mM). The equilibrium potentials for each ion can be calculated using the
Nerst equation:
Ein-Eout = - RT * 2.303 log ([X]in / [X]out) / zF
where [X]in and [X]out are the concentrations of ion X across a membrane, R is the
ideal gas constant, T is the temperature in Kelvin, F is Faraday’s constant and z is
the ion valence.

The equilibrium potential for Cl- (ECl) in skeletal muscle is
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approximately -90 mV, near this tissue’s resting membrane potential, so the net
movement of Cl- at resting membrane potential is near zero. EK in skeletal muscle
is about -100 mV, resulting in a small net movement of K+ ions out of the cell. ENa
is approximately +65 mV, thus both the electrical and concentration forces on Na +
drive it into the cell.
As described supra vide, a significant portion of a cell’s energy is expended
by the Na-K-ATPase to maintain Na+ and K+ gradients against their
electrochemical equilibria. This pump moves 3 Na+ ions out of the cell for every 2
K+ that moves in, causing a net positive charge to exit the cell, and is thus termed
“electrogenic”. In itself, this net movement of positive charge out of the cell is
responsible for ~-5 mV of a neuron’s or skeletal and cardiac muscles’ resting
membrane potential. In other cell types, such as smooth muscle, it may contribute
over -20 mV to the transmembrane voltage difference. While its direct effect on
membrane potential is not insignificant, its true indispensible function is the
maintenance of the K+/Na+ gradient utilized by voltage-gated channels.
By far the greatest contribution to membrane potential in excitable cells is
the utilization of passive diffusion of Na+ and K+ down their electrochemical
gradients though variably conductive pores. The conductance of a membrane to
an ion can be described as the sum of the conductance of various ion channels to
which that ion is permeant. This relationship is described by the chord conductance
equation:
Em = (gK*Ek)/(gK + gNa + gCl) + (gNa*ENa)/(gK + gNa + gCl) +(gCl*ECl/(gK + gNa + gCl)
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Where g is the conductance of the membrane to the noted ion and E is the
equilibrium potential to the noted ion and Em is the equilibrium potential of the
membrane. As a membrane becomes more permeant to a particular ion, the
membrane potential is driven toward the equilibrium potential of that ion. In the
cardiac myocyte and neuron, the relative steady-state gK+ is high, thus the resting
membrane potential is near the equilibrium potential for K +. During the action
potential, the relative gNa+ increases drastically and Na+ rushes into the cell,
causing rapid depolarization to near ENa of approximately +65 mV. Membrane
potential is then restituted as gNa+ rapidly falls and gK+ increases, driving the cell
back toward the EK of about -90 mV. It is the finely tuned activity of multiple families
of voltage-gated ion channels that both maintain and make use of this form of
potential energy to accomplish a wide range of functions in various electrically
active cell types.

The action potential
An action potential is a rapid depolarization in membrane potential followed
by a return to resting membrane potential. The shape, duration and size of action
potentials differ considerably between excitable tissues, reflective of the diverse
populations of voltage-gated ion channels functionally expressed on a tissue and
cell type-specific basis. While virtually all mammalian cell types express some
combination of voltage-gated ion channels, only cells in the nervous system,
muscle (skeletal and cardiac) and some neuroendocrine cells exhibit classical
action potential firing patterns. These tissues exhibit what can be considered the
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evolutionarily conserved purpose of the action potential: finely tuned management
of intracellular calcium levels through the activation of voltage-dependent calcium
channels.

Calcium is unique when compared to other ions in that its

transmembrane concentration gradient is very large; basal cytosolic calcium
concentration in most cells is on the order of 10-8 to 10-7 M, compared to 10-3 M in
extracellular fluids. Comparatively, intracellular and extracellular concentrations
of both Na+ and K+ differ by 1 to 2 orders of magnitude.
Cells expend a great deal of energy to maintain nanomolar [Ca 2+]i, by
actively transporting it out of the cell or into dedicated internal stores such as the
sarcoplasmic reticulum. This finely tuned management is necessary because
calcium acts as a second messenger, coupling electrical activities with many
cellular events. Disruption of calcium homeostasis has detrimental effects on cell
physiology, and prolonged elevation of intracellular calcium levels is common to
both pathological (necrotic) and programmed (apoptotic) cell death, as well as
contractile dysfunction in muscle.
In neurons, calcium entry through voltage-gated Ca2+ channels initiates
synaptic transmission. In this process, calcium-sensitive synaptotagmins in the
presynaptic terminal are activated by the transient rise in calcium concentration.
These secretory proteins transduce the chemical Ca2+ signal to the exocytotic
machinery, causing neurotransmitter release. The synaptotagmins are common to
most other Ca2+-regulated exocytotic processes, including hormone release from
endocrine and neuroendocrine cells.
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In muscle cells, calcium acts as a second messenger transducing cellular
depolarization with contraction, a process known as excitation-contraction
coupling.

Activation

of

sarcolemmal voltage-gated

Ca2+ channels by

depolarization results in the entry of calcium ions that further promote Ca2+ release
through the ryanodine receptor from the sarcosplasmic reticulum. The excitationcontraction signaling terminates on the myofilament apparatus; calcium binds to
one of 4 high affinity sites on troponin C, causing a conformational change that
displaces tropomyosin from its actin binding sites.

This allows crossbridging

between the actin and myosin filaments, resulting in the power stroke that is the
functional hallmark of muscle tissue.
Restitution of nanomolar cytosolic calcium levels is accomplished through
active transport out of the cell through the plasma membrane Ca 2+-ATPase
(PMCA) and the Na+-Ca2+ exchanger (NCX) and into internal stores through the
sarcoplasmic reticulum ATPase (SERCA). In the mammalian myocardium, Ca2+
extrusion is dominated by SERCA (70-90%) and NCX (10-30%).6
In order to turn off the stimuli of the excitation-contraction and exocytotic
pathways, i.e. calcium entry through voltage-gated Ca2+ channels, the cell must
repolarize to membrane potentials at which the open probability of these channels
is negligible. The preponderance of this repolarization is accomplished by the
activation of the voltage-gated K+ channels.

Voltage-gated K+ channels
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The voltage-gated K+ channel (Kv) family represents one of the most
diverse families of ion channels. The products of these gene families have 6
transmembrane spanning domains (S1-S6) and assemble tetramerically through
association of an N-terminal tetramerization (T1) domain to form a central ionconducting pore. Over 40 mammalian Kv channel α-subunits encoded by 11 gene
families (Kv1-Kv11) have been identified to date. These proteins form channels
that vary widely in their gating properties, kinetics, and pharmacology. Even within
gene families, different genes may encode for alpha subunits with vastly different
properties (i.e. Kv1.4 and Kv1.5 generate rapidly-inactivating A-type currents and
non-inactivating delayed rectifier currents, respectively). Their functional diversity
is further underscored by the fact that different alpha subunits of the same family
may heterotetramerize in vivo, such as Kv1.2/Kv1.5 in vascular smooth muscle 7
and Kv1.3/Kv1.5 in T-lymphocytes.8 This produces functional channels with gating
and pharmacological properties intermediate to that of homotetramers formed from
their individual components. Furthermore, the gating and pharmacology of Kv
channels is altered by ancillary beta subunits, which include Kcne, KChIP, and Kvβ
family proteins. The result is an impressive functional diversity that matches
repolarization dynamics to a cell’s requirements. The critical role of ancillary Kv
channel subunits is demonstrated by the fact that mutations in these proteins have
been linked to a various pathologies in both humans and animals, including cardiac
arrhythmias, hypertension, epilepsy and learning deficits.9 10
Not unexpectedly, mutations in Kv alpha subunits are also associated with
a wide range of diseases. Mutations in Kv1 family members cause ataxia,11
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epilepsy,12 atrial arrhythmias,13-15 and olfactory deficits.16 Mutations in the Kv2
family have been linked to reduced left ventricular mass17 and infantile epilepsy.18
Kv3 mutations are associated with spinocerebellar ataxia and cognitive defects 19
and antibiotic-induced cardiac arrhythmia.20 A truncation in Kv4.2 has been linked
to temporal lobe epilepsy.21

Genome wide association studies (GWAS) will

undoubtedly uncover more genetic variants responsible for channelopathies
afflicting various tissues and organs.

Kv channel structure and function
The first mammalian Kv structure resolved with x-ray crystolography
brought great insight into the structure-function relationship of this channel
family.22 In this work, Kv1.2 from Rattus norvegicus was determined to a resolution
of 2.9 Å, elucidating the structures and mechanisms responsible for voltage
sensing and electromechanical coupling involved in the opening of the ionconducting central pore. This study built upon structural descriptions of the
prokaryotic K+ channels KcsA and KvAP, which elucidated the amino acid bases
for the K+ selectivity filter (transmembrane segments S5 and S6), voltage sensing
(transmembrane segments S1-S4) and central pore formation.23, 24 These works
confirmed the tetrameric association of α-subunits, arranged in four-fold symmetry
around the central axis forming the conduction pore (Figure 1.1).
The selectivity filter is lined with carbonyl groups along a 12 Å segment of
the S6 along the central pore. These electronegative carbonyls coordinate with
the cation and allow for the dehydration of K + ions as they enter the central pore.
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In the aqueous environment of the central pore, the K + ion is resolvated and
expelled into the extracellular space by electrostatic forces. A consensus
sequence (Thr-Val-Gly-Try/Phe-Gly) in the selectivity filter is highly conserved
throughout evolution and is present in almost all K + channels. The atomic radius
of Na+ (0.96 Å) is smaller than that of K+ (1.33 Å), and thus cannot fully coordinate
with the carbonyls of the selectivity filter, resulting in a 104-fold preference for the
passage of K+ over Na+.
The defining characteristic of Kv channels is their ability to sense and
respond to changes in the transmembrane potential by altering their conductance.
This process is dependent on four key arginine residues located on the S4 TM
segment, loosely attached to the perimeter of the pore.

Upon changes in

membrane transmembrane potential, the positively charged sidechains of these 4
arginine residues from each of the 4 tetramerically arranged α-subunits transfer a
total of 12-14 positive elemental charges across the membrane electric field from
inside to outside. The movement of these residues is transduced through the S4S5 linker helix to constrict or dilate the S6 helix that forms the inner part of the
pore, thus allowing the voltage sensor to perform mechanical work on the pore.25
This process comprises the activation gating of the voltage-gated ion channel,
allowing for the conductance of K+ ions down their electrochemical gradient as the
S6 region causes pore dilation (open state). Membrane repolarization removes
the electrical field effect on the voltage sensing domains, causing them to return
to their initial position. This movement is transduced via the same S4-S5 linker
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helix to the S6 helix lining the pore returning it to its original constricted (closed)
state in a process known as deactivation.
In addition to activation and deactivation gating, voltage-gated ion channels
can occupy a third gating state: the inactivated state. Inactivation of a channel
occurs when it enters into a stable, non-conducting conformational state from an
activated state following membrane depolarization. When in the inactivated state,
a channel cannot conduct ions even if the transmembrane potential is favorable.
Inactivation of an ion channel is accomplished through two mechanisms: C-type
inactivation and N-type inactivation (Figure 1.2). The C-type inactivation property
was initially discovered when it was found that some voltage-gated channels
displayed inactivation kinetics that were dependent upon splice variations in the Cterminus.9 This mode of inactivation was also found to be independent of Nterminal deletion. C-type inactivation, which typically occurs on a slow time scale
(10-1-100 s), involves extracellular conformational changes in the channel that
result in the occlusion of the outer mouth of the ion-conducting central pore.26 Like
activation, the return to the active channel state is voltage dependent.

This

indicates that C-type inactivation is coupled to movement of the voltage sensing
S4 domain during its initial response to membrane depolarization. Recovery from
inactivation occurs as the membrane is repolarized and the S4 domain returns to
its original location, transducing a mechanical signal to open the pore mouth. Ctype inactivation has been observed in all members of the Kv1 family. It also occurs
in the related Kv4 and hERG (human ether-a-go-go related gene) family channels,
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but with much faster recovery from inactivation kinetics, indicating a different
molecular mechanism.27
N-type inactivation, also known as ball and chain inactivation and fast
inactivation, occurs with much more rapid kinetics (10-3 to 10-2 s) (Figure 1.3).
Channels that display N-type inactivation contain an N-terminal domain of
approximately 20 amino acids that are critical to this mechanism. This N-terminus
“ball” is followed by 60 amino acids in the “chain” domain.

Mutagenesis

experiments on the N-terminus of the Kv1 drosophila homolog ShakerB
demonstrated that the charge of the ball domain is critical to inactivation;
increasing the positive charge in this region increases the rate of inactivation and
conversely, decreasing the positive charge slows the rate of inactivation.28 Upon
channel activation and pore opening, a negatively charged surface on the pore
mouth is exposed.

This region electrostatically interacts with the positively

charged residues in the N-terminus (the inactivation particle), rapidly occluding the
conduction pore and placing the channel in an inactivated state. Recovery from
N-type inactivation to the closed but non-inactivated state requires the removal of
the N-terminus inactivation particle from the pore. The time course of recovery
from inactivation is voltage dependent and sensitive to extracellular [K +], which
indicates a mechanism in which a K+ ion displaces or destabilizes the interaction
between the pore and the inactivation particle.29
A Kv channel’s activation, inactivation, and recovery from activation kinetics
are important in determining its contribution to cellular repolarization. A rapidly
activating and rapidly inactivating current such as the A-type currents generated
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by Kv1.4 and Kv4.2 have a transient contribution to a cell’s repolarization,
providing brief bursts of current early in the action potential that is not sustained.
In the heart and neuron, these A-type currents are prominent and responsible for
the early phase of repolarization.

Slowly activating but rapidly inactivating

currents, such as those generated by hERG in the heart, provide repolarization
capacity only later in the action potential. Rapidly activating slowly inactivating
currents, such as the cardiac Ikur (ultrarapid delayed rectifier potassium current),
provide sustained repolarization capacity throughout the duration of the action
potential. Recovery from inactivation kinetics also dictates a channel’s contribution
to repolarization on a use-dependent basis. High-frequency action potential firing,
as seen in the central nervous system, require rapid Kv channel recovery from
inactivation to ensure their availability to participate in a series of repolarizing
events.30

Conversely, prolonged Kv recovery from inactivation contributes to

frequency dependent increases in excitability and changes in action potential
shape. This phenomena is well documented in the heart; the rate dependence of
action potential duration and refractoriness in the ventricular endocardium differs
from that of the epicardium.31 At the molecular level, the transient outward current,
Ito, which dominates the early phase of cardiomyocyte repolarization, is generated
by two different ion channels, Kv1.4 and Kv4.2. These channels have significantly
different rates of recovery from inactivation; Kv1.4 recovery occurs on the order of
seconds32 while Kv4.2 recovers in milliseconds.33 Thus, the currents encoded by
these channels are known as Ito,slow and Ito,fast, respectively. The assymetrical
distribution of these channels across the transmural gradient of the ventricular wall
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is responsible for regional differences in repolarization and believed to be a
mechanism by which to prevent re-entrant arrhythmias.34, 35

Kv channel ancillary subunits
When expressed in heterologous expression systems in vitro, Kvα- subunits
form functional channels on their own. In vivo, Kv channels are found to be
coassembled with ancillary subunits in heteromultimeric protein complexes that
modulate their gating kinetics (activation, inactivation, recovery from inactivation),
pharmacology, and trafficking. Mutations in these subunits are associated with
multiple pathologies in both human and animals, including hypertension, epilepsy,
arrythmogenesis, hypothyroidism and periodic paralysis,10 which underscores their
physiological importance.
Four families of ancillary subunits are associated in vivo with members of
the Kv superfamily: KChIPs (Kv channel interacting proteins), KCNE (i.e. mink,
minimal potassium channel subunit), DPPLs (dipeptidyl aminopeptidase-like
proteins), and the Kvβs.

These subunits may associate with only one Kv

subfamily, as demonstrated in KChIP preference for Kv4 channels, or with multiple
Kv subfamilies, as with Kvβ proteins’ interaction with Kv1 and Kv4 members.
Furthermore, their structures and mechanisms of physical interaction with the
halochannel are distinct. This is clearly demonstrated in the case of Kv4, which
may associate in vivo with KChIP, DPPL, and Kvβ proteins simultaneously.
Members of the same subunit family may have different or opposing effects on
channel gating or trafficking. Much of the information on subunit modulation of
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channel function has been garnered through in vitro experiments and is described
at the single cell level.

Animal models harboring subunit point and deletion

mutations have also given insight into the function of these proteins.

KChIPs
The K+ channel interacting proteins (KChIPs) associate with the cytosolic
domain of Kv4 channels. Kv4 channels are highly expressed in the ventricular
myocardium, where they generate the cardiac transient outward current Ito,fast
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and in dendrites of central neurons, where they generate the A-type current.37 The
association of various KChIPs with Kv4 produce channel complexes exhibiting a
wide range of activation, inactivation and recovery from inactivation kinetics.38
Alternative splicing of the products of the four known KChIP genes (KChIP1-4)
makes it the most diverse family of Kv channel subunits.
The binding of KChIPs to the Kv4 N-terminus alters both the voltagedependence and time course of the Kv4 current in a manner that is dependent on
both KChIP subunit and Kv4 isoform composition. Different KChIPs also have
profound and differential effects on current density, presumably through altering
surface expression. For example, KChIP1 increases the rate of Kv4.1 inactivation
but causes a 4-fold decrease in the rate of Kv4.2 inactivation.39

KChIP1

depolarizes the voltage dependence of activation (V 1,2-act) of Kv4.1 by
approximately 10 mV but hyperpolarizes the Kv4.2 V1,2-act by up to -40 mV.
Coexpression of KChIP1 with Kv4.2 causes a 15-fold decrease in expression
whereas coexpression of KChIP2 with Kv4.2 causes a 55-fold increase in surface
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expression.40 Clearly, the association of KChIPs with different Kv4 members
produce channel complexes exhibiting a profound range of electrophysiological
signatures.

DPPLs
The dipeptidyl aminopeptidase-like proteins (DPPLs) modify the effects of
KChIPs on Kv channels. Heterologous expression of Kv4 with various KChIPs did
not fully reconstitute the kinetics of A-type currents recorded from primary neurons,
despite

strong

evidence

that

they

originated

from

Kv4.2.

Indeed,

coimmunoprecipitation of Kv4 in rat brain membranes revealed an association with
DPPX, a protein of then unknown function.41 Co-expression of this protein with
Kv4.2 in Xenopus oocytes caused a large increase in current density by facilitating
trafficking and surface expression. It also accelerated the rate of inactivation and
recovery from inactivation. When the Kv4.2/KChIP2/DPPX complex was
expressed, current properties better matched the A-type kinetics found in neurons
and the Ito kinetics in the heart.42

KCNEs
The KCNE gene family encodes single-pass integral membrane proteins
that associated with members of the Kv7 family (KCNQ) early in their maturation
and assist in their trafficking and alter their gating. KCNE1 interacts with Kv7.1 to
slow its time course of activation, right-shift its current-voltage relationship, reduce
inactivation and increase single channel conductance43 and increase its surface
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expression.44

Together, Kv7.1 and KCNE1 form the slow delayed rectifier

potassium current Iks, a prominent delayed rectifying current in the heart.45 Of the
4 families of ancillary Kv subunits, KCNE probably has the most critical function in
the heart; mutations in KCNE1 are associated with the life threatening long QT
syndrome.46 Mutations in KCNE2-5 are also associated with other ventricular and
atrial arrhythmias.10 Interestingly, KCNE proteins display promiscuous binding to
many members of the Kv superfamily, including Kv1, Kv2, Kv3, Kv4, and Kv11
(hERG).44

The interaction with hERG, which generates the delayed rectifier

potassium current IKr, is of particular importance to the proper functioning of the
heart. hERG plays a critical role in cardiac repolarization due to multiple known
mutations in this gene linked to arrhythmias47 and the variety of drugs known to
interact with the hERG channel to cause QT interval prolongation.48

The Kvβ subunits
Structure of the Kvβ proteins
The Kvβ protein was first discovered in rat brain membranes by
chromatography when it co-eluted from a dendrotoxin 1 (DTX-1) affinity column.49
The purified proteins were run on a gel and silver stained, showing 3 bands. One
band at 76-80 kDa, corresponded to the column target, the DTX-1-sensitive alpha
subunit, which was known to be a member of the Kv1 channel family. Two other
bands at 35 kDa (determined to be a degradation product) and 38 kDa of unknown
origin were also revealed.

The molecular weights of these proteins closely

matched that of the products of the Drosophila A-type K+ channel, which seemed
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to contain peptides of 70 and 35 kDa, and was cloned a year earlier.50 Together
these studies gave the first evidences of the heteromultimeric α 4β4 composition
that functional Kv channels assume in vivo.
The concept of auxiliary subunits modulating the electrophysiological
properties of ion channels had already been described for Na+

51

and Ca2+

channels,52 and established a precedent for the functionality of the newly
discovered Kv β-subunit. Furthermore, cloned DTX-1-sensitive channels were
known to be responsible for the synaptic A-type current in rat brain neurons, yet
expression of these and other related Kv1 clones in Xenopus oocytes produced
current with strikingly different inactivation characteristics.9, 53
Rettig and Pongs54 were the first to demonstrate that Xenopus oocyte coexpression of a β-subunit (Kvβ1) with members of the Kv1 family converted the
non-inactivating Kv1 current into a rapidly inactivating current, quantitatively similar
to the neuronal A-type current (Figure 1.4). In this study, Kvβ1 and Kvβ2 cDNA
were cloned from the rat brain and their protein products compared; alignment
showed a C-terminal sequence that was 85% identical and an N-terminal domain
of 79 amino acids that were present in Kvβ1 but not Kvβ2. Hydropathy analysis
and N-glycosylation patters indicated that the Kvβ proteins were cytosolic.
Alignment of the Kvβ1 N-terminus with the N-termini of rapidly inactivating Kv1.4
and Kv3.4 demonstrated high homology in the “ball” region. Electrophysiological
assays demonstrated that Kvβ1 imparted rapid inactivation to the non-inactivating
RCK1 (Kv1.1). Furthermore, coexpression of Kvβ1 with an N-terminal truncation
mutant of Kv1.4 lacking its ball and chain region restored rapid inactivation
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properties to the channel complex, which indicated that the Kvβ1 proteins can
provide the inactivating ball in a manner analogous to the N-type inactivation of
Kv1.4. Consistent with this model, Kvβ2, which has a shorter N-terminal domain,
is not found to induce N-type inactivation in delayed rectifying channels, although
when assembled with Kv1.5, Kvβ2 causes a -10 mV shift in the activation threshold
and accelerates channel activation. Kvβ2 also has been shown to modestly
accelerate inactivation of Kv1.4 currents.55 Kvβ3, which possesses an inactivating
ball region with 90% sequence identity to that of Kvβ1 has been subsequently
found to impart rapid inactivation to slowly inactivating Kv1.5 channels.56
Follow up studies investigated the nature of the association of the Kvβ
subunits with various members of the Kv family. It was found that Kvβ1 and Kvβ2
expressed in COS-1 cells associated with all known members of the Kv1 family
with similar affinities but not with the Kv2 or Kv3 families.57 Kvβ1 and Kvβ2 also
coimmunoprecipitated with Kv4.2. The non-covalent nature of the α-β interaction
was confirmed by noting the detergent sensitivity of the immunoprecipitation
process, yet interaction was strong enough to withstand high salt treatment.58
Interestingly, the interaction between Kvβ and Kv1 (dissociated by 0.2% SDS) is
more detergent sensitive than that between Kvβ and Kv4 (not dissociated by
<0.6% SDS).57 In Kv1 channels, the N-terminal contains a hydrophilic NAB (Nterminal A and B box) region that is necessary for α-subunit tetramierization.59 This
domain, the T1 tetramerization domain, also contains a structural motif
FYE/QLGE/DEAM/L in Kv1.560 that is necessary for Kvβ1-mediated inactivation of
the channel.61 NAB domains within the Kv1-Kv4 families share about 40% amino

19

acid identity59, 62; α-subunits of these different families do not tetramerize. NAB
domains share about 70% within subfamilies, which is enough to allow for
heterotetramerization. The Kv4 α-subunits homology in this region with Kv1 is
insufficient for Kvβ interaction; they associate with Kvβ by a distinct mechanism
that is C-terminus but not N-terminus dependent.63 Thus, Kvβ utilize distinct
molecular mechanisms to interface with these two families of Kv channels.

Phosphorylation
The primary structures of Kvβ suggest the presence of 15 consensus
phosphorylation sites: 1 for PKA, 10 for PKC, and 4 for casein kinase II.64 Protein
kinase A phosphorylation of N-terminus serine 24 in Kvβ1.3 has been
demonstrated to decrease its inactivation effect on Kv1.5 and thus to increase
outward current.65 The effect of this phosphorylation event is unsurprising given
its location—addition of negative charge at or near the inactivation ball inhibits its
interaction with the open pore of the Kvα. PKC-dependent phosphorylation of
Kvβ1.2 using phorbol 12-myristate 13-acetate (PMA) decreases the current
conducted by Kv1.5/Kvβ1.2 complexes by depolarizing the voltage dependence of
activation.66
Aside from the effects of on channel complex gating, phosphorylation also
regulates export from the endoplasmic reticulum and cell surface trafficking.67 The
association of Kvα and Kvβ subunits occurs during translation in the ER, with
maturation of the complex into its α4β4 form completing before ER export.68, 69 The
Kvβ proteins are known to increase surface expression of Kv1 channels (described
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in more detail below). The positive membrane trafficking effect on Kv1.2 by Kvβ2
is dependent on phosphorylation of α-subunit at Ser 440 and Ser 441.70
Phosphorylation of Kvβ2 at Ser 9 and Ser 41 was also shown to be critical to the
increase in Kv1.2 at the cell membrane.

Cycline-dependent kinase (Cdk)

phosphorylation of Kvβ2 at Ser9 and Ser 31 regulates axonal targeting of Kv1
channels in the hippocampus.71 These neurons have a highly localized distribution
of Kv1.1 and Kv1.2 channels at the juxtaparonode, which is lost both by genetic
knockout of Kvβ2 or Ser/Ala mutations at the phosphorylation sites.

The

mechanism of this effect occurs through the microtubule plus end-tracking protein
(EB1) domain of Kvβ2, phosphorylation at S9 and S31 by Cdk2 and Cdk5 disrupts
its binding to EB1, promoting its dissociation from microtubules and insertion into
the membrane. In vivo, Kvβ2 is found in complex with the atypical protein kinase
C zeta (PKC-ζ), connected by the scaffolding proteins PKC-ξ interacting proteins
1 and 2 (ZIP1 and ZIP2).72 The purpose of PKC-ξ phosphorylation is not fully
elucidated, but inhibition of PKC-ξ activity may play a role in the ceramidedependent inhibition of Kv currents in pulmonary artery smooth muscle.73

The Kvβ proteins are functional enzymes
Three human Kvβ genes undergo alternative splicing to form a total of 6 Kvβ
proteins (amino acid length): Kvβ1.1 (401), Kvβ1.2 (408), Kvβ1.3 (419), Kvβ2.1
(367), Kvβ2.2 (353) and Kvβ3 (404). The Kvβ proteins are members of the aldoketo reductase (AKR) superfamily that includes 15 individual families of
oxidoreductases involved in carbonyl metabolism. Members of individual families
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share at least 40% sequence homology with each other and <40% homology with
other AKRs. All AKRs share a (β/α)8 triosephosphateisomerase-barrel structural
fold in which the active site is located at the C-terminus. These proteins do not
contain a Rossmann fold, but they bind pyridine nucleotides with high affinity via
unique AKR nucleotide binding domains (discussed below).
The AKR nature of Kvβ proteins was first identified by the significant
homology between the amino acid sequence of the Shaker β-subunit and proteins
of the AKR superfamily.74 Amino acid alignments also showed that the AKR
residues involved in cofactor binding are conserved in the Shaker β-subunit.75 In
accordance with these predictions, our lab found that purified Kvβ proteins bind to
pyridine nucleotides with high affinity (Kd values between 0.1 and 6 μmol/L).76 In
vitro these proteins bind NADP(H) with higher affinity than NAD(H). However, the
nature of the cofactor bound to Kvβ in vivo is unclear, because NAD(H) levels in
excitable tissues are 2- to 7-fold higher than that of NADP(H); therefore, it is
possible that the lower affinity of Kvβ for NAD(H) is offset by higher NAD(H) levels
in the cell. Hence, the extent and the nature of the nucleotide bound to Kvβ in vivo
may depend on the prevailing concentration of all 4 nucleotides in a cell. We
believe that this might allow the Kvβ to respond to a wide range of metabolic
conditions by being sensitive to changes in both NADP(H) and NAD(H) levels.
To examine the functional effects of pyridine nucleotide binding, our group
previously studied Kvβ1.3-mediated inactivation of Kv1.5 expressed in COS-7
cells (Figure 1.5).77 Our lab found that oxidized nucleotides (NAD[P]+) prevent
inactivation, whereas reduced nucleotides have no effect. These findings have
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been corroborated and expanded by subsequent investigations, which have
shown that NAD(P)+ removes the inactivation of Kv1.1 by Kvβ178 and Kv1.5
inactivation by Kvβ3.79

NAD(P)+ also has been shown to prevent the Kvβ2-

mediated hyperpolarizing shift in Kv1.5 activation79 and the acceleration of Kv1.4
current inactivation.80

The results of whole-cell patch-clamp have been

substantiated by excised inside-out single-channel experiments in which it was
found that the mean open time and the open probability of Kv1.5+Kvβ1.3 77 and
Kv1.1+Kvβ178 currents are increased by adding NAD+ to the perfusate. The
specificity of these interactions has been established by site-directed mutagenesis
studies, which indicate that active site mutations that prevent nucleotide binding
abolish the effects of NAD(P)+ on current inactivation.81 Additional mutagenesis
and domain-deletion experiments have shown that oxidized nucleotides promote
the binding of Kvβ N-terminus to the core of the protein and thereby remove
inactivation by preventing the N-terminus from blocking the channel.82 This
interaction also may be regulated by the cytosolic C-terminus of the membranespanning channel protein. For instance, it has been reported that deletion of Kv1.5
C-terminus prevents NAD(P)+-mediated removal of inactivation by Kvβ3.79
Moreover, even though NAD(P)H does not affect Kv1.5 inactivation by Kvβ1.3,77
it accelerates Kv1.5 inactivation by Kvβ379.

Collectively, these observations

indicate that pyridine nucleotides bind directly to the Kvβ active site and that
NAD(P)+ binding induces a specific conformational change that prevents Kvβinduced inactivation, whereas NADP(H) binding preserves or promotes
inactivation.

23

Kv1 currents in the myocardium and the cardiac action potential
The coordinated contraction and relaxation of cardiac muscle is necessary
for the efficient pumping of blood. Synchronized contraction requires the rapid
electrical activation of cardiac myocytes throughout the entire heart.

This is

accomplished through very low resistance connections, the gap junction proteins,
which connect adjacent myocytes at the intercalated disk. These proteins form
physical connections between cells that freely allow the passage of ions and
other small molecules. The electrical syncytium formed by these cytoplasmic
connections allows the depolarizing wave to be rapidly transmitted across the
heart.
Action potential morphology differs considerably between species, but the
mechanisms of depolarization and propagation are highly conserved; in all
mammalian hearts, cardiac action potential upstroke (depolarization) is
accomplished by the activation and subsequent inactivation of voltage-gated Na+
channels.

The substantial interspecies variation is attributed primarily to

heterogeneous expression of Kv and L-type Ca2+ channels, which is reflected in
the time course of myocardial repolarization (Figure 1.6).
Repolarizing K+ currents can be broadly segregated into two categories, the
transient outward currents, Ito, and the outwardly rectifying currents, IK.36 Within
each category, multiple subclasses exist, which display distinct kinetic and
pharmacological properties. In the mouse heart, two transient outward currents
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can be distinguished, Ito,fast and Ito,slow, which vary in their recovery from inactivation
and pharmacological properties. The expression of these two currents also differs
spatially; while Ito,fast can be recorded from all areas of the ventricular myocardium,
including the interventricular septum, Ito,slow expression is restricted to the
septum.83 Outwardly rectifying currents in the mouse myocardium are described
by three currents with various kinetics, IK,slow1, IK,slow2, and Isustained (or Iss).83, 84 No
regionally distinct expression profile has been determined for these outward
rectifiers. Inwardly rectifying K+ currents of the KIR class also play a role in human
but not mouse cardiac repolarization and set the resting membrane potential of the
cardiac myocyte in both species.36

The molecular identities of mouse cardiac Kv currents
The transient outward current Ito
Kv1.4 was the first gene cloned from the mammalian heart that encoded a
rapidly inactivating K+ current.85 The cDNA for this gene, called RHK1 at the time,
was isolated from a rat heart library and revealed a deduced amino acid sequence
displaying characteristics of the Shaker voltage-gated K+ channels recently cloned
from Drosophila: six segments corresponding to transmembrane domains, a
domain homologous to the S4 voltage-sensor domain and a leucine zipper domain
found between S4 and S5. Southern blot analysis demonstrated expression of this
gene was restricted to the brain and heart, with an absence in smooth and skeletal
muscle. Expression of the cloned gene in Xenopus oocytes generated an A-type
rapidly inactivating current with activation and inactivation time courses and
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voltage dependences that were grossly similar to the I to current recorded from rat
cardiac myocytes. The time course of recovery from inactivation for the cloned
RHK1 gene differed substantially from that of Ito. With the limited but growing
understanding of the effects of ancillary Kv subunits, it was reasonably speculated
that the oocyte expression system might have lacked a protein responsible for
modifying the recovery rate of the channel.
Shortly thereafter, Tamkum et al. cloned another set of K+ channel genes
from rat heart and aorta cDNA libraries.86 Five channels were cloned, four of which
(RK1-RK4) were identical or similar to other Kv1 genes identified previously. The
fifth, RK5, encoded a unique channel with a sequence homology to the Drosophila
Shal family (now known to be homologous to the mammalian Kv4 family), and
stood as the first report of Shal family channel expression in a mammalian tissue.
cDNAs of this gene were expressed in Xenopus oocytes in subsequent work for
electrophysiological characterization.87,

88

These studies showed that rat Shal

gave rise to rapidly activating and rapidly inactivating voltage-gated K+ channels
with voltage dependences of activation and inactivation similar to both neuronal Atype K+ currents and cardiac Ito.

Slight differences in pharmacology and

inactivation time course between the RK5/Shal4 and native Ito currents have since
been attributed to differential KChIP subunit expression in the heart and brain.10
Ensuing studies combining molecular and electrophysiological approaches
to elucidated the contributions of Shaker RCK4 and Shal RK5 in generation of
cardiac Ito. Early studies demonstrated that the kinetics of I to varied across the
ventricular wall and in different regions of the heart. This was examined eloquently
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by Backx et al., who demonstrated regionally restricted Kv1.4 and Kv4.2 protein
expression and a transmurally graded protein expression of Kv4.2 in the rodent
heart.89 The later finding was subsequently explained by differential transmural
KChiP expression by the transcription factor Irx5.90
Many evidences by several groups support that the cardiac transient
outward current is actually two regionally-restricted currents, Ito,fast (Ito,f) and Ito,slow
(Ito,s), attributable to Kv4 and Kv1.4 respectively.

In addition to their spatial

distribution, the two transient outward currents in the mouse myocardium can be
distinguished readily based on their pharmacology and rates of recovery from
inactivation matching their molecular correlates.91 The Ito,f current displays a rapid
recovery from steady state inactivation (on the order of 10s through hundreds of
milliseconds) and is sensitive to the giant crab spider toxin Heteropoda toxin at
nanomolar concentrations. Pharmacologicial isolation of Ito,f using Heteropoda
toxin (HpTx2) demonstrates that this current displays A-type rapid inactivation and
activation at relatively polarized membrane potentials.83 Together, these provided
more evidence that Kv4.2 is the molecular correlate of the Ito,f current in mice. This
finding was further substantiated by Marban et al., who suppressed rat ventricular
Ito using viral infection of a dominant-negative truncated Kv4.2 construct.92 Follow
up studies indicated that in larger animals, including humans and dog, Ito,f is
encoded by the closely related Kv4.3.93 The Ito,f current is highly conserved in the
mammalian heart, having been well characterized in human, dog, cat, rat and
mouse ventricular myocytes.94 The Ito,slow current is predominantly found in the
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septum of mice and atrium of humans, which mirrors the protein expression of
Kv1.4.89, 95
Although the physiological importance of cardiac Kv1.4 is not as defined as
it is for Kv4.2, the relationship between the two appears to be of importance in
disease. Many experimental and genetic models of heart failure and hypertrophy
cause a decrease in ventricular Ito current density.96

In humans, Kv4.3 is

downregulated in heart failure.97 In diabetic animals, Kv4.2 message and protein
is reduced while Kv1.4 transcript and protein is increased, mimicking the changes
in Ito kinetics in diabetes.98-101 This so called “isoform switching” between Kv4.2
and Kv1.4 in the diabetic heart is being investigated as a possible contribution to
increased incidence of ventricular arrhythmias in diabetic patients.

The outwardly rectifying currents IK,slow1 and IK,slow2
Whereas the mouse and human generate their transient outward currents
through Kv4.2/Kv4.3 and Kv1.4 channels, their generation of delayed rectifying
currents occurs through distinct molecular mechanisms. The human ventricular
delayed rectifying currents are distinguishable as three components, IKur
(IK(ultrarapid)), IKr (IK(rapid)), and IKs (IK(slow)), which are categorized based on the their
rate of activation.36 The inactivation of these currents is slow enough such that
they play a significant role in repolarization throughout phase 3 of the human action
potential (Figure 1.2). IKr and IKs can be detected in human myocytes isolated from
the ventricles while IKur is a completely atrial current in humans. The α-subunits
responsible for generating these currents has been established after years of
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intensive research. The molecular correlate of IKr is hERG (also known as Kv11.1),
the product of the gene KCNH2. The IKs current is generated by the KVLQT1
channel (also known as Kv7.1), the product of human KCNQ1. The IKur current is
generated by Kv1.5, the product of the Shaker-related gene KCNA5.

These

channels are of immense clinical importance as mutations in and inadvertent
pharmacological interactions with these channels are responsible for a multitude
of channelopathies, including Long QT syndrome, Short QT syndrome, Familial
Atrial Fibrillation, torsades de pointes, and idiopathic lone atrial fibrillation.36
While hERG and KVLQT1 are not expressed in the mouse heart, Kv1.5 is
a predominant current in the mouse ventricle.102 Initial investigations into mouse
ventricular Kv currents demonstrated a very slowly inactivating component, termed
IK,slow, played a significant role in myocyte repolarization.

Pharmacological

approaches at characterizing the channel responsible for this current revealed two
distinct components. One component was sensitive to micromolar concentrations
of 4-aminopyridine (4-AP), strongly indicative of Kv1-family contribution.

The

second component was 4-AP insensitive but sensitive to tetraethylammonium
(TEA), suggesting Kv2 family involvement. Transgenic mice were also generated
to further identify the channels involved in the IK,slow current. The targeted genetic
replacement of Kv1.5 with a truncated Kv1.1 to created a functional Kv1.5
knockout mouse removed the 4-AP sensitive component of IK,slow and increased
the incidence of spontaneous and triggered arrhythmias and caused QT
prolongation.102 A functional Kv2.1 knockout mouse was generated using a
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dominant negative mutant, Kv2.1-N216, which eliminated the TEA-sensitive
component of IK,slow and increased action potential duration.103
The properties of mouse IK,slow1 are indistinguishable from the IKur found in atrial
myocytes from larger animals, including human,83, 104, 105 and it is now accepted
that Kv1.5 encodes the human atrial IKur. Indeed, Kv1.5 has become a target in
the development of drugs to treat atrial arrhythmias.106,

107

Perhaps not

unexpectedly, many of the anti-arrhythmic compounds develop against Kv1.5 have
had off target affects on other ion channels,108 underscoring the structural and
pharmacological similarities of the multiple Kv-family channels that play a role in
cardiac repolarization. The development of Kv1.5-specific anti-arrhythmic agents
remain a major focus of the pharmaceutical industry.107 Furthermore, the critical
role of Kv1.5 in human atrial function is demonstrated in its remodeling in patients
with chronic atrial fibrillation where its protein abundance is reduced by up to
60%.13, 109

30

Figure 1.1: Overall structure of the Kv1.2 tetramer. viewed from the extracellular solution,
shown as ribbons. Each of the four subunits is colored uniquely. The transmembrane helices
S1 to S6 are labeled for the subunit colored in red. Each S4 helix (red, for example) is nearest
the S5 helix of a neighboring subunit (blue, for example). Adapted from Long SB et al. Science
2005; 309:903-908
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Figure 1.2: Models of N-type and C-type inactivation of K+ channels. A) N-type
inactivation is dependent on an N-terminal inactivation “ball” domain B) C-type inactivation
involves the closure of the extracellular mouth of the channel. Adapted from Rasmusson RL
et al. Circ Res. 1998;82:739-750
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Figure 1.3: C-type and N-type inactivating currents. Outward currents elicited by a +50
mV depolarizing pulse from a holding potential of -100mV. Left: RCK1 (Kv1.1) lacks an Nterminal inactivation domain and inactivates by a slow C-type mechanism. Right: RCK4
(Kv1.4) has an N-terminal “ball” domain and rapdily inactivates upon channel opening.
Adapted from Rettig et al. Nature. 1994 May 26; 369(6478):289-94
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Figure 1.4: Kvβ1 imparts rapid N-type inactivation. Coexpression of Kvβ1 converts the
slowly inactivating RCK1 (Kv1.1) into a rapidly inactivating channel complex. Adapted from
Rettig et al. Nature. 1994 May 26; 369(6478):289-94.
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Figure 1.5: Model of physiological regulation of voltage-gated potassium (Kv)
channel by pyridine nucleotides. A, Composite representation of the Kvα–Kvβ
complex. The membrane-spanning domains of Kvα are shown in blue. The T1 domain,
which docks with Kvβ, is shown in light blue. The N-terminus of Kvβ forms the
inactivating ball and chain assembly. In the NADPH-bound state of the Kvβ subunit, the
N-terminal domain of Kvβ inactivates the channel by plugging the internal opening of
the ion-permeation pathway, resulting in N-type inactivation (right). Binding of NADP+
to Kvβ prevents inactivation. For clarity, only 2 of the 4 subunits of Kvα and β are shown.
B, Schematic showing the regulation of channel function by NADPH. The
noninactivated (open) state of the channel is stabilized by NADP+, whereas NADPH
binding induces inactivation. The transition between the inactivated and noninactivated
state of the channel is mediated either by pyridine nucleotide exchange or by catalytic
turnover involving the substrate-dependent conversion of NADPH to NADP+. C, Effect
of NAD+ on single channel Kv activity in inside-out patches recorded in COS-7 cells
expressing Kvα1.5 and Kvβ1.3 before and after exposure to 1 mmol/L NAD +. Currents
recorded in response to a +50-mV depolarizing pulse. Reprinted with permission from
Am J Physiol Cell Physiol, Tipparaju et al.42D, Stereoview of a ribbon representation
showing the side view of the channel complex containing the transmembrane (TM)
domain, the T1 scaffolding, and the auxiliary β-subunits. The NADP+ cofactor bound to
each β-subunit is shown as indicated.36 (Illustration: Ben Smith.) Adapted from Kilfoil
PJ et al Circ Res. 2013;112:721-741
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Figure 1.6: Action potentials and underlying ionic currents. Adult human (left) and mouse
(right) ventricular myocytes have diverse outward K+ currents while inward Na+ and Ca2+ currents
are similar. The diversity of K+ currents results in distinct action potential repolarization shapes in
human and mouse ventricular cells. Adapted from Nerbonne JM Trends Cardiovasc Med. 2004
Apr;14(3):83-93.
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CHAPTER II
DETAILED MATERIALS AND METHODS

Immunoprecipitations and Western Blot Analysis
Western blot analyses were performed on fractionated protein lysates
prepared from whole heart, isolated ventricular cardiomyocytes, and whole brain
tissue from adult (12 to 22 week) Kvβ2 WT and Kvβ2 -/- mice to examine Kv1.4,
Kv1.5, Kv4.2, Kvβ1 and Kvβ2 expression patterns. All antibodies used in this study
are commercially available, have been previously tested for specificity and crossreactivity and have been shown to be subunit specific. For Western blot analyses,
proteins were fractionated on SDS-PAGE gels (any-kD or 7.5%, BioRad),
transferred to PVDF membranes followed by overnight incubation at 4°C with a
(polyclonal or monoclonal) anti-Kvβ2 (K17/70, Neuromab, Davis, CA), anti-Kv1.4
(K13/31, Neuromab), or anti-Kv1.5 (APC-004, Alomone, Jeruselum, Israel)
antibody. Following thorough washing, the membranes were incubated with
horseradish

peroxidase-conjugated

anti-mouse

or

anti-rabbit

secondary

antibodies. The membranes were again thoroughly washed to remove excess
substrate and then bound antibodies were detected using luminescent horseradish
peroxidase substrate (Pierce ECL/ECL Plus, Thermoscientific) and scanned on
Typhoon.
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For immunoprecipitations, 50 µL protein G-coated magnetic beads (Dynabeads
Protein G, 10003D, Life Technologies) were incubated with rocking overnight at
4°C with 10 µg of anti-Kvβ2 (K17/70), Kv1.4 (K13/31), Kv1.5 (APC-004) or Kv4.2
(K57/1) antibody in 200 µL PBS plus 0.01% TWEEN-20 (to prevent bead
aggregation). To decrease the signal from antibody heavy and light chains on
Western blot, the antibodies were then cross-linked to the beads. This was
achieved by first washing the beads twice each with 1 mL of sodium borate (50
mM, pH 9.0) followed by 30 min incubation by rocking at room temperature with 1
mL of 25 mM dimethyl pimelimidate made fresh in 50 mM sodium borate. After
removing the supernatant, the beads were resuspended in 1 mL of ethanolamine
and incubated by rocking for 2 hours at room temperature. The beads were then
washed gently with 1 mL PBS plus 0.01% TWEEN-20 three times. Once crosslinking was complete, lysates were incubated with the beads by rocking overnight
at 4°C. The supernatant was removed and saved. The beads were resuspended
in 1:5 SDS loading buffer with 150 mM DTT in PBS plus 0.01% TWEEN-20 and
then heated at 70°C for 10 min. The supernatant was then removed and boiled at
100°C for 10 min. The eluted sample was then fractionated and immunoblotted as
described above.
Differential centrifugation was used to prepare membrane-enriched fractions from
heart lysates. In this procedure, hearts were homogenized in chilled glass in cold
lysis buffer containing (in mM): mannitol 225, sucrose 75, EGTA 0.1, Tris-HCl 30,
pH 7.4. Protease and phosphatase inhibitor cocktails (Sigma) were added at a
1:100 concentration. The lysate was centrifuged at 3000 RPM for 10 min to
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remove cellular debris and unbroken cells. The supernatant was removed and set
aside on ice while the pellet was resuspended in lysis buffer and again
homogenized.

The 3000RPM spin was repeated on this lysate and the

supernatants were pooled. The collected supernatants were then centrifuged at
124,000g for 1 hour at 4° C. The supernatant was removed and the pellet was
resuspended in 200 μL of buffer containing (in mM): Tris 50, EDTA 1 and 2%
sarkosyl.

The pellet was pipetted and the solution sonicated 5 times for 30

seconds until completely dissolved. Protein content was then measured by Lowry’s
method and separated by SDS PAGE.

Electrophysiological Recordings
Cardiomyocytes isolated from the mouse ventricles were used for
electrophysiological recordings.

Whole-cell voltage-clamp and current-clamp

experiments were performed within 12 hours of cell isolation at the temperatures
noted using an Axopatch 200B patch-clamp amplifier (Axon Instruments, Foster
City, CA). For voltage-clamp experiments, cells were patched using borosilicate
glass pipettes (1B150F-4 and TW150F-4, World Precision Instruments, Sarasota,
FL) pulled using a Sutter P-87 (Sutter Instrument, Novato, CA) to a resistance of
2-4 MΩ when filled with a pipette solution containing (in mM): K-aspartate 100, KCl
30, MgCl2 1, HEPES 5, EGTA 5, Mg-ATP 5, NaCl 5, pH adjusted to 7.2 with KOH.
For current clamp experiments, pipette resistance was 7-10 MΩ when filled with
the same solution. Cardiomyocytes were placed in a 0.25mL recording chamber
(RC-26, Warner Instruments, Hamden, CT) and perfused with an external solution
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containing (in mM): NaCl 135, MgCl2 1.1, CaCl2 1.8, KCl 5.4, HEPES 10, glucose
5.5, pH 7.4 adjusted with NaOH. CdCl2 (0.3 mM) was added to the bath solution
for voltage-clamp experiments.

In experiments done at near physiological

temperature, perfusate heating was controlled using an inline heater (64-0103,
Warner Instruments) and heated magnetic platform (PM-1, Warner Instruments),
controlled by a bipolar dual automatic temperature controller (TC-344B, Warner
Instruments).

Only quiescent, single, rod-shaped cardiomyocytes with clear

striations were selected for recording. In voltage-clamp experiments, cells were
held at -80 mV and depolarized for 5 sec to potentials from -100 mV to +50 mV in
10 mV steps at 0.05 Hz. In some experiments, cells were depolarized to a single
potential of +50 mV from the same holding of -80 mV. All voltage clamp protocols
were preceded by a 50 ms inactivating prepulse to -40 mV to eliminate Na+
currents.110 Whole-cell series resistances and capacitances were electronically
compensated at least 80% to minimize voltage error. Action potentials were
evoked by the injection of a small, short lasting current (0.8-2 nA, 1-2 ms) at 1.0
Hz. Cells were paced for 30 seconds to reach steady state and the final 5 action
potentials were averaged for analysis.

Analysis of electrophysiological recordings
Voltage-clamp data were analyzed using Clampfit 9 (Axon Instruments).
Peak currents were defined as the maximal K+ current reached over the period of
depolarization. The amplitudes and inactivation time constants of outward currents
were best-fit using tri-exponential curve fitting, which was performed in Clampfit
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using the Levenberg-Merquot (SP) iterative technique.

Only fittings with a

correlation ≥ 0.98 were used in analysis. Peak and component amplitudes were
normalized by cell capacitance and expressed in pA/pF. Cell membrane
capacitance were calculated immediately upon reaching whole-cell configuration
by Clampfit through integration of the transient seen in response to a +10 mV
voltage step from holding. Action potentials were analyzed using a custom written
Visual Basic program in Microsoft Excel to calculate resting membrane potential,
action potential amplitude, dV/dtmaz, and action potential durations at 20%
(APD20), 50% (APD50) and 90% (APD90) repolarization. Action potentials
recorded after 30 sec pacing at 1 Hz were used for comparison.

Mice
Male Kvβ2-/- mice as well as strain-matched WT mice were bred in house
and maintained on a mixed C56BL/6 x 129/SvEv background. The Kvβ2 -/- mice
were originally obtained from Dr. Geoffrey Murphy of the University of Michigan
Department of Physiology and The Molecular & Behavioral Neurosciences
Institute. All procedures were approved by the University of Louisville Institutional
Animal Care and Use Committee, IACUC number 14047.

Isolation of adult mouse cardiac myocytes
Male mice 12-24 weeks of age were used for cardiac myocyte isolation.
Twenty minutes prior to anesthetization, an intraperitoneal injection of heparin
sodium salt (>350 USP units, H3149, Sigma Aldrich) was administered to prevent
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blood clotting in the coronary vasculature upon excision of the heart. Mice were
anesthetized by an intraperitoneal injection of sodium pentobarbital (160mg/kg)
and placed in a supine position with limbs restrained by tape. Upon positive
confirmation of full anesthesia by paw pinch, the heart was rapidly and gently
removed by thoracotomy and placed in a 70mm petri dish containing ice-cold
(~1°C) calcium-free phosphate buffer solution (Gibco, ThermoFisher Scientific).
Any non-cardiac tissue attached to the heart was rapidly removed while the heart
was submerged in PBS, and the aorta was identified. Using microfine foreceps,
the aorta was lifted onto a 22-gauge cannula attached to a modified Langendorff
system and the heart was secured to the cannula using #4-0 surgical suture. The
heart was perfused in retrograde Langendorff mode with buffers maintained at
37°C using a water-jacketed heat exchanger (Radnotti LLC, Monrovia CA) and
negative feedback heated water bath and pump. Upon canulation, the heart was
perfused with Tyrode’s solution containing (in mM) NaHCO3 18, NaCl 126, KCl 4.4,
MgCl2 1, HEPES 4, glucose 11, BDM 10, Taurine 30, pH 7.4) under a constant
pressure of 70mm Hg. The perfusion of this first calcium-free buffer serves the
purpose of removing all blood from the coronary vasculature as well as causing
the dissociation of gap junctions which aids in myocyte isolation. Perfusion of
calcium-free Tyrode’s solution was no longer than 5 min to avoid a decline in
myocyte health due to the “calcium paradox”,

111, 112

a phenomenon wherein

reintroduction to physiological Ca2+ levels (1-3 mM) following perfusion of Ca2+free buffer causes rapid deterioration of cell quality and myocyte hypercontracture
due to Ca2+ influx.
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After 5 minutes, the perfusion solution was exchanged with an enzyme
solution consisting of the above Tyrode’s solution with the addition of Liberase TH
280μg/mL, CaCl2 25μM, endotoxin-free BSA 0.1%, DNAse (Roche) 15μg/mL,
protease type XIV (Sigma Aldrich) 16.8μg/mL, pH 7.4 with NaOH. The heart was
digested for approximately 8-10 minutes and then inspected visually for proper
digestion. The ventricles were then cut off the cannula and the heart was placed
in a 35 mm dish containing mincing solution at 37°C comprised of the above
enzyme solution with the addition of BSA 9mg/mL. In this buffer, any remaining
vasculature or nonventricular tissues were quickly dissected away and the heart
was minced using fine tip forceps until most large pieces of tissue were gone. The
tissue and cells were then gently triturated by aspirating the solution with a
serological pipette several times. The cell-containing solution was passed through
a 100-mesh stainless steel filter to remove any underdigested tissue. The filtered
solution containing dissociated cardiac myocytes were then purified of damaged
or calcium intolerant cells by reintroducing calcium in 5 steps of increasing
concentration. Cardiac myocytes were allowed 10 minutes to pellet in 5 tubes
containing 50 μM, 75 μM, 125 μM, 275 μM and 525 μM CaCl2. Following this final
stage, a small aliquot (10 μL) of suspended cells was transferred to a
hemocytometer for counting and inspection of isolation quality. Using this protocol,
over 1 * 106 cardiac myocytes (>90 % rod shaped with long aspect ratio) are
routinely obtained.
For electrophysiological experiments, the cardiac myocytes were then
suspended in a cold (4°C), high K+ solution containing (in mM): K+-glutamate 100,
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KCl 25, KH2PO4 10, MgSO4 1, glucose 22, EGTA 0.5, HEPES 5, pH 7.2 with KOH.
Cells were stored in the refrigerator until study, at which time a small aliquot of
suspended cells was transferred into the bath of the patch clamp microscope.
For immunofluorescence imaging studies, the cardiac myocytes were fixed
as follows. Cells were allowed to pellet in a 15 mL test tube and any remaining
buffer was aspirated. The pellet was then resuspended in 2 mL of calcium-free
PBS 4°C. Cold paraformaldehyde (4% in PBS) was then slowly added to the
suspension for a final concentration of 3% PFA and allowed to incubate for 15 min
total. The first 10 minutes of fixation was performed with gentle rocking, and during
the final 5 minutes the tube was placed upright to allow the cells to pellet. The
fixed cardiac myocytes were washed 3 with 15 mL of cold PBS, allowing 15
minutes during each wash to allow the cells to pellet at the bottom of the tube.
Following the final wash step, the cells were suspended in 2 mL of PBS and stored
at 4°C for up to 3 months.
For protein and mRNA analysis, the pellet of cells was flash frozen in liquid
N2 and stored at -80°C for later use.

Cell Immunofluorescence
For immunofluorescent studies, 3000-5000 fixed cardiac myocytes were
diluted into approximately 100μL and adhered to poly-L-lysine-coated coverslips
using a Cytospin 4 Cytocentrifuge (Thermo Scientific) at 300 RPM. This produced
an even distribution of cells without significant cell overlap and no disruption in
morphology.
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Cells were permeabilized by incubating in PBS containing 0.1% Triton X-100 for
10 minutes. The permeabilized myocytes were then washed in PBS three times
for 5 min. Blocking was performed by incubating the cells in 1% BSA, 22.5 mg/mL
glycine in PBS T (PBS + 0.1% Tween 20) for 30 minutes.
Primary antibody incubation dilutions were determined empirically for each
antibody. Primary antibodies were diluted in 1% BSA in PBST and incubated for
either 1 hour at room temperature or overnight at 4°C in a humidified chamber.
Following primary antibody incubation, the cells were washed in PBS 3 times for 5
minutes.
Secondary antibodies, anti-rabbit or anti-mouse Alexa 647 (ThermoFisher
Scientific) were diluted in 1% BSA at a concentration of 1:2500. Cells were
incubated in the secondary antibody for 45 minutes at room temperature in an
opaque box.

Cells were then washed again in PBS 3 times for 5 minutes.

Coverslips were then quickly dunked into a beaker containing deionized water, as
we have found this minimizes the presence of any salt crystals formed by
evaporation. Cells were counterstained with ProLong Antifade reagent containing
4,6-diamidino-2-phenylindole (DAPI, ThermoFisher Scientific), covered with a 12
mm coverslip and sealed using clear nail polish. Cells were stored in a slide box
at 4°C until analyzed. Fluorescence was observed using a Nikon A1 confocal
microscope equipped with a 405 nm laser (for DAPI) and a 632 nm laser (for Alexa
647).

Echocardiography
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Transthoracic echocardiography was performed using the Vevo 770
echocardiography platform. Mice were anesthetized using 2% isoflurane initially,
and were maintained under anesthesia for the remainder of the experiment using
1.5% isoflurane. Body temperature was maintained at 37°C using an electronic
rectal

thermometer

interfaced

to

a

servo-controlled

heating

lamp.

Electrocardiograms were recorded using leads attached to each limb. Mice were
placed supine on an examination board and depilatory cream was used to remove
all hair on chest. Two-dimensional imaging of the parasternal long axis was
performed using a 707-B 30 MHz scan head at 100 frames per second. Short axis
images were also recorded by rotating the scan head. Two-dimensional images
were obtained every millimeter between the papillary muscles and the apex. Mmode images were constructed from 2-D images and were used to measure heart
rate (HR), left ventricular inner diameter during diastole and systole (LVIDd and
LVIDs, respectively). These measures were used to calculate fractional shortening
(FS) using the equation:

FS= [(LVIDd-LVIDs)/LVIDd] x 100%.

Ventricular

volumetric indices (diastolic and systolic volumes) were calculated using
Simpson’s rule of integration on the serially acquired short-axis images. These
were used to calculate stroke volume (SV) as SV=diastolic volume – systolic
volume. Ejection fraction (EF) was calculated as EF= (stroke volume/diastolic
volume) 100%. Cardiac output (CO) was calculated as: CO= SV * HR.

Cardiac histology
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Hearts were rapidly excised and mounted on a 22-gauge blunted needle
cannula as with the cardiac myocyte isolation protocol and were retrogradely
perfused with room temperature PBS for 3 minutes followed by 4% PFA in PBS
for 15 minutes. Hearts were then removed from the cannula, dissected of any nonmyocardial tissues, and sectioned in either the coronal, sagittal or axial axes using
a Zivic Mouse Heart Slicer (Zivic Instruments, Pittsburgh, PA) and incubated
overnight in 4% PFA. The next morning, the heart sections were transferred to a
beaker containing 70% ethanol for short-term storage. Heart sections were then
processed and embedded in paraffin blocks for long term storage.

Paraffin-

embedded tissue sections were sliced at 4 μm and stained with H&E. Images of
mid-heart cross sections were made using a digital camera mounted to an
Olympus microscope.

Quantitative RT-PCR
RNA was extracted from heart samples using the RNeasy mini kit (Qiagen).
RNA concentration and purity was measured using the Nanodrop 1000A
Spectrophotometer (Thermo Scientific). The cDNA library was prepared using a
Bio-Rad mycycler Thermocycler at 42°C for 60 min and 94°C for 5 min. When not
used immediately, cDNA samples were stored at -20°C. Total cDNA were diluted
20-fold using RNAse free water prior to use. RT-qPCR was done using iTax
Universal SYBR Green Supermix (Bio-Rad) on the Applied Biosystems 7900 HT
Real-Time PCR system. Primers for Kvα, Kvβ, and mGAPDH (internal control)
were added to wells of a 384-well plate appropriately. cDNAs for each RNA
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sample were run in triplicate. The RQ of each Kv channel subunit in each sample
were calculated using the 2-ΔΔCt method by normalization to the internal standard
mGAPDH. Specific amplification was confirmed by visualizing melting curves for
each sample for the presence of a single sharp peak.

Statistics
Data are reported as mean ± SEM. Data were analyzed using GraphPad
Prism and Microsoft Excel with paired or unpaired t-test with Bonferroni correction
or ANOVA. For paired experiments where treatment values were normalized to
initial values, the Wilcoxon matched pairs nonparametric test was used. P-values
<0.05 were considered to be significant.
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CHAPTER III
Kvβ2 MODULATES CARDIAC Kv CURRENTS AND REPOLARIZATION
Introduction
The voltage-gated potassium (Kv) channels are widely expressed
throughout excitable tissues and are the primary mediators of repolarization in
neurons and the cardiac myocyte. In the heart, Kv channels regulate the resting
membrane potential, the frequency of pacemaker and the shape and duration of
the action potential.106 As a superfamily consisting of over 40 different members,
they form one of the most diverse ion channel families both in form and function.
Their functional diversity is further expanded through the interaction with ancillary
subunits, such as the Kvβ proteins. These cytoplasmic subunits, which bind to the
intracellular domain of Kv1 and Kv4 family channels, can have profound effects on
channel trafficking and membrane expression,63, 68, 113 subcellular localization,71,
114

and channel gating and kinetics.54, 56, 115, 116
Much of the information regarding the electrophysiological and catalytic

functions of the Kvβ proteins has been gained through the use of heterologous
expression systems. While much of both in vivo and primary cell characterization
have been performed in the central nervous system, some descriptions of the
physiological function of Kvβ proteins in other tissues and organs do exist. The
loss of Kvβ1 in the heart has been demonstrated to alter the cardiac Kv currents
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Ito,f and Ik,slow.117 Furthermore, antisense knock down of Kvβ2 has been
demonstrated to reduce Kv conductance, hyperpolarize the conductance-voltage
relationship (V1/2-act, the voltage at which half the channels in a cell are in an
activated state), increase the time course of current activation (τact, a measure of
the rate of current change) and increase action potential duration in Xenopus
myocytes.118 Kvβ2-/- mice also have a strong strain-dependent neurological
phenotype. In mice on a C57BL/6 background, loss of Kvβ2 leads to deficits in
memory and learning and causes occasional seizures.119
Therefore, we designed the present study to address our hypothesis that
Kvβ2 plays a role in ventricular repolarization through a contribution to the
generation of cardiac Kv currents by its interaction with one or more unknown
members of the Kv family. To this end, we used an approach that included single
cell patch clamp and organ-level (Langendorff perfused heart) electrophysiology,
protein measurement by Western blotting, co-immunoprecipitation, and cellular
immunofluorescence. We also assayed cardiac function using echocardiography
to determine if contractile function of the heart was altered. Together, we aimed
to determine the cardiac phenotype of mice bearing a targeted disruption of the
Kvβ2 gene (Kvβ2-/-) vs. their WT littermates.

Results
Kvβ2 expression in the mouse ventricle
Western blotting of whole-heart lysates was performed to confirm the
presence of Kvβ2 protein in mouse ventricular lysates (Figure 3.1). We also
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performed immunoblotting to determine if the loss of Kvβ2 impacts the protein
expression of Kvα and Kvβ subunits previously described to interact with Kvβ2 in
other cell types (Figure 3.1).

Using whole-cell ventricular lysates, protein levels

of Kv1.4, Kv1.5, and Kv4.2 were not significantly altered in ventricles from Kvβ2 -/mice (Figure 3.2). To confirm cardiac myocyte expression of Kvβ2, isolated cardiac
myocytes were fixed with paraformaldehyde, permeabilized and stained with a
monoclonal anti-Kvβ2 antibody and anti-mouse Alexa 647 secondary antibody.
Cells were viewed under confocal microscopy and it was shown that the greatest
fluorescent intensity was localized to the sarcolemma (Figure 3.3).

Kvβ2 interacts with Kv1.4 and Kv1.5 in the mouse heart
Biochemical and electrophysiological work using expression systems has
previously established that Kvβ2 interacts with most members of the Kv1 10 and
Kv457, 63, 120 families both physically and functionally. In the brain, Kvβ2 has been
shown to associate with Kv1.1, Kv1.2, Kv1.4, Kv1.6 121 and Kv4.3,63 with Kv1.3 in
lymphocytes122 and Kv1.5 in pancreatic islets.123 Previous work demonstrated that
Kvβ1 directly interacts with Kv4.2 and Kv4.3, but not Kv1.4 or Kv1.5 in the mouse
heart.117
To determine the in vivo binding partners of Kvβ2 in the mouse heart, a coimmunoprecipitation approach using magnetic bead-bound monocolonal antiKvβ2 antibody was utilized. Western blot analysis of ventricular lysates showed
that Kv1.4 and Kv1.5 coimmunoprecipitate with Kvβ2. (Figure 3.4). No positive
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co-immunoprecipitation was observed in lysates prepared from Kvβ2-/- hearts,
supporting the specificity of the interaction.

Loss of Kvβ2 decreases surface expression of Kv1.5 in ventricular cardiac
myocytes
In heterologous systems, co-expression of Kvβ proteins increases the
membrane expression of Kv1 and Kv4 channels.10, 124 To determine the effect of
Kvβ2 on surface expression of Kv1.4, Kv1.5 and Kv4.2 channels, we compared
the abundance of these Kv channels on the surface of ventricular cardiac myocytes
isolated from WT and Kvβ2-/- mice. To this end, two techniques were utilized:
sarcolemmal membrane fractionation using differential centrifugation and confocal
microscopy of fixed isolated cardiac myocytes.
Whereas the total Kv1.5 protein in Kvβ2-/- ventricles was slightly greater
than in WT (Figure 3.1), the ratio of Kv1.5 in the membrane-enriched fraction to
that in supernatant was significantly reduced in Kvβ2 -/- ventricular lysates (Figure
3.5); this result suggests a role for Kvβ2 in moving Kv1.5 to the sarcolemma. The
efficacy of the membrane separation protocol was confirmed by comparing pancadherin detection in the membrane (M) and cytosolic (S) fractions (Figure 3.5),
suggesting that all sarcolemmal protein was contained in the membrane-enriched
fraction. Furthermore, in accordance with findings in the literature, the membrane
bound Kv1.5 was found as a single band, whereas Kv1.5 from whole cell
preparations typically runs at two bands of distinct molecular weights. In support
of this finding, isolated cardiac myocytes were fixed and stained with anti-Kv1.5

52

antibody and visualized under confocal microscopy.

Surface fluorescence of

Kv1.5 was reduced in Kvβ2-/- cardiac myocytes compared to WT controls (Figure
3.6).

Together, these findings indicate a role for Kvβ2 in the surface expression

of Kv1.5 channels in the heart.

Loss of Kvβ2 reduces outward Kv current in ventricular cardiac myocytes
To investigate whether Kv currents in cardiac myocytes were altered due to
loss of Kvβ2, whole-cell voltage clamp (Figure 3.7) was used to compare the
magnitude and time course of currents elicited in response to 5s, +50mV
depolarizing pulses. Triexponential fitting was used to dissect currents into three
components based upon inactivation time constants.105 Peak current density
(Ipeak) was reduced in Kvβ2-/- (p < 0.05, Figure 3.8 A-C). The magnitude of current
associated with the most rapidly inactivating exponential component, previously
described to be attributed to Ito, was reduced from 30.0+/- 4.6 pA/pF in WT to 15.8
+/- 2.0 pA/pF in Kvβ2-/- (p<0.01 Figure 3.8 D). The magnitude of intermediate and
slowly inactivating currents were reduced but did not reach statistical significance
(p=0.13 and p=0.054, respectively, Figure 3.8 E,F). The inactivation time constant
values associated with each exponential term were not different between groups
(Table 1).

Reduced Kv current magnitude results in delayed action potential
repolarization
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As Kv currents are the driving force for cardiac myocyte repolarization, we
tested whether the reduced Kv current densities observed in voltage-clamp
conditions manifested in prolonged action potential durations. Action potential
repolarization was quantified as the time required for a cell to return to 20, 50, and
90% of its resting membrane potential (APD20, APD50, and APD90).
Repolarization was slowed significantly at each APD, indicating a significant
repolarization deficit in Kvβ2-/- myocytes (Figure 3.9 B). Other action potential
parameters including upstroke velocity (dV/dtmax), resting membrane potential
(RMP), and action potential amplitude (APA) were unchanged, confirming that the
changes caused by loss of Kvβ2 are specific to repolarization and not due to broad
electrophysiological instability or cell health (Figure 3.10). We found that action
potential duration was similarly prolonged by a partial blockade of Kv1.5 with the
Kv channel blocker 4-aminopyridine. At the concentration used (100 μM), we
expected approximately 30% inhibition of Kv1.5 (IC50 270 μM) 10, similar to the
reduction in peak Kv current observed under voltage clamp. Prolongation of action
potentials by 4-AP was qualitatively similar to that observed in the Kvβ2-/- cells
(Figure 3.9 C).
To further confirm a repolarization deficit in the Kvβ2-/- heart, we perfomed
a second series of experiments using the ex vivo Langendorff perfused heart
model. Monophasic action potentials were recorded from the epicardial surface of
the left ventricle during spontaneous beating (Figure 3.11 A-C). In agreement with
the transmembrane action potentials recorded from single isolated cardiac
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myocytes, action potentials were significantly prolonged at 20, 50, and 90%
repolarization (Figure 3.11 D-F).

Baseline cardiac function is unchanged in Kvβ2-/- hearts
To examine if the prolonged cardiac repolarization seen in Kvβ2-/manifested in changes in contractile function, we performed transthoracic
echocardiography. All functional cardiac parameters, including stroke volume,
ejection fraction and cardiac output were unchanged (Figure 3.12).

We did find

through necropsy study that Kvβ2-/- mice have smaller hearts than age- and sexmatched WT mice. The heart weight to tibia length ratio in Kvβ2-/- is significantly
lower in Kvβ2-/- compared to age-matched WT (6.2 ± 0.1 mg/mm vs 7.4 ± 0.3
mg/mm respectively, p < 0.002, Figure 3.13 A). This difference resulted from
differential development in the left ventricle (Figure 3.13 B) as right ventricular
development (Figure 3.13 C) was not different between groups. Some hearts were
sectioned in the transverse plane and stained with hematoxylin and eosin to
compare gross anatomy and to visualize left ventricular development (Figure 3.13
D). This difference does not arise from changes in cardiac myocyte size, which
was not different between groups as measured either by microscopy or cellular
capacitance during electrophysiological experiments (Figure 3.14).

Discussion
The results of this study show that Kvβ2 plays a role in repolarization in the
heart through enhancement of Kv current density. We found that Kvβ2 protein is
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expressed in the heart, specifically in the cardiac myocyte. We found that Kvβ2
physically associates with Kv1.4 and Kv1.5 in vivo, and plays a role in the
functional expression of Kv currents through enhanced Kv current density. The
significant reduction in peak current density in response to depolarization appears
to be driven by a reduction in Ito, as the triexponential fitting model employed
showed the largest reduction in the magnitude in the most rapidly inactivating
component of the outward current. This is evidence to suggest a functional
interaction of Kvβ2 with Kv4.2 or Kv1.4, channels it is known to both associate with
and promote the surface trafficking of. We attempted to co-immunoprecipitate
Kv4.2 using the method that showed positive interaction with Kv1.4 and Kv1.5, but
were not able to detect this protein in the immunoprecipitated material. This is not
definitive evidence for a lack of interaction of Kv4.2 with Kvβ2 in the heart, but it
suggests that the reduction in Kv current may be occurring by another mechanism.
One interpretation of our results is that the observed reduction in surface
expression of Kv1.5 in the Kvβ2-/- could be participating in the reduction of peak
current. Kv1.5, the molecular correlate of the human I kur current is very rapidly
activating; under voltage clamp conditions when the cell is depolarized to +50 mV,
it almost instantaneously activates and contributes to the peak current density.
This however does not explain a contribution to the rapidly inactivating component
of the outward current. The most plausible explanation for the reduced rapidly
inactivating current aside from an interaction of Kvβ2 with Kv4.2, which was not
detected by Co-IP, is that Kvβ2 is interacting with Kv1.4 in the WT heart. Indeed,
we found positive co-immunoprecipitation with Kv1.4. The magnitude of the current
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with an intermediate inactivation rate, IK,slow1 was reduced but not to a statistically
significant level. This could be a result of a limitation in the fitting algorithm used.
Recent work published since the time of these experiments supports the notion
that 5 sec depolarizations are not adequately long enough to fully resolve the three
components of the murine Kv currents, Ito, IK,slow1 and IK,slow2 and that
depolarizations lasting as long as 20 seconds may be required to accurately
separate the magnitudes of each Kv current.125 (Liu J 189) Nevertheless, we
interpret the findings of significantly reduced Kv current density, positive coimmunoprecipitation with Kv1.4 and Kv1.5, and reduced trafficking of Kv1.5 to the
sarcolemma as strong evidences of a critical role of Kvβ2 in the generation of
repolarizing currents in the mouse heart.
The impact of the observed reduction in Kv current is clear; in both single
cell current-clamp and monophasic action potential recordings, Kvβ2 hearts have
a significantly reduced repolarization capacity.

Action potential durations are

prolonged at all levels of repolarization, strongly indicating an effect on the rapidly
activating components of the total cardiac Kv current, I to and IK,slow1. This is
supportive of voltage clamp results and the observed interactions with Kv1.4 and
Kv1.5, components of Ito and IK,slow1, respectively. Further work is warranted to
confirm whether Kvβ2 is interacting with Kv4.2 in the mouse heart.
In addition to the effects that Kvβ2 appears to have on the functional
expression of Kv channels, that is the enhancement of Kv channel abundance at
the sarcolemma, the results can also be interpreted as evidence that the loss of
Kvβ2 may affect the gating of Kv1.4 and Kv1.5 in the heart. While the voltage
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clamp results do not show any significant differences in inactivation rates of the
three Kv component currents, we did not specifically address changes in their
voltage dependence of activation, V1/2-act. Accurately measuring the V1/2-act of a
singly expressed channel in a heterologous system is straightforward, doing so in
a primary cell that contains many different currents is not. We have not yet
addressed this experimentally, in part due to the fact that the pharmacology of
Kv1.5 inhibitors is lacking.

The Kv1.5 blockers commercially available are

chemical blockers that are not as highly specific as peptide inhibitors (i.e. spider
toxins like HpTx) available for other channels. Inhibition of IK,slow1/Kv1.5 with
channel blockers such as 4-AP and Psora-4 likely would not allow for the very
precise inhibition necessary to allow for measurement of activation kinetics. One
potential compound to address this question does exist, diphenyl phosphine oxide
(DPO-1), which blocks Kv1.5 in the sub micromolar range with an 8-fold specificity
over Ito. This may be addressed in future experiments as we further characterize
the mechanism by which Kvβ2 modulates cardiac Kv currents.
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Figure 3.1: Expression of Kvα and Kvβ proteins in the mouse ventricle.
Whole heart lysates were separated by SDS PAGE and incubated with antiKv4.2, Kv1.5, Kvβ1.1, Kvβ1.2, Kvβ2 and KChIP2 antibodies.. Kvβ2 protein is
expressed in WT (lanes 1-3) but not Kvβ2-/- (lanes 4-6) hearts.
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Figure 3.2: Quantification of Western immunoblots. Western
blots from Figure 3.1 were quantified using ImageJ. . Detection of
Kv1.5 was slightly increased (p<0.05). n=3 WT and 3 Kvβ2-/- hearts.
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Figure 3.3: Cellular localization of Kvβ2 by immunofluorescence.
Confocal microscopic images showing fixed isolated cardiac myocytes from
WT (left) and Kvβ2-/- (right) mice stained with anti-Kvβ2 primary antibody
(1:100) and Alexa647 secondary antibody. Red: anti-Kvβ2. Blue: DAPI.
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Figure 3.4: Immunoprecipitation of Kv1.4 and Kv1.5 by Kvβ2. Lysates prepared
from isolated adult ventricles were immunoprecipitated (IP) using monoclonal antiKvβ2, antibody. Lysates before IP were also blotted with the same antibodies. Both
Kv1.4 and Kv1.5 co-immunoprecipitate with Kvβ2 and are not detected in
immunoprecipitation with Kvβ2/- ventricular lysates.
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Figure 3.5: Ratio of Kv1.5 in the sarcolemma to cytosol. Top: A membrane
preparation protocol was used to separate and enrich plasma membrane proteins. The
efficacy of the separation was confirmed by blotting for pan-cadherin, a protein exclusively
found in the sarcolemma. Center: For each heart (4WT and 6KO), two lanes were
loaded, one with the membrane fraction (left) and cytosolic fraction (right). The band
intensity of each pair was compared to find a membrane:cytosolic Kv1.5 ratio for that
heart. Note: membrane bound Kv1.5 appears as a single band, cytosolic Kv1.5 appears
as a double band, both bands were included. Bottom: Quantification of the group
means, membrane:cytosolic ratio was significantly reduced in Kvβ2 -/- (p<0.05).
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Figure 3.6: Cellular localization of Kv1.5. Isolated cardiac myocytes were stained with
an extracelluar epitope anti-Kv1.5 antibody with secondary Alexa647 staining and viewed
under confocal microscopy. Relative to WT, Kvβ2-/- showed reduced surface Kv1.5
reactivity. Result is representative of 3 experiments.
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Figure 3.7: Isolated ventricular cardiac myocyte being recorded under
whole-cell voltage-clamp configuration. Rpipette=2.5 MΩ
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Figure 3.8: Kv currents in isolated cardiac myocytes. Representative outward
current traces recorded from WT (A) and Kvβ2-/- (B) ventricular cardiac myocytes in
response to a family of 5s depolarizing pulses from -90 to +60 mV (Δ=10mV) from a
holding potential of -80mV. Peak outward current density in response to +50 mV was
significantly reduced (C). Tri-exponential fitting of current responses to a 5s 50mV
depolarizing pulse was used to deconvolve individual currents based on inactivation
rates (D-F). The magnitude of the rapidly inactivating current was significantly
reduced by loss of Kvβ2. (*: p<0.01). N=# mice, n= # cells recorded.
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Figure 3.9:
Action potentials in ventricular cardiac myocytes.
A.
Representative action potentials recorded from ventricular cardiomyocytes isolated
from WT and Kvβ2-/- mice. B. Transmembrane action potentials of right ventricular
cardiac myocytes were prologned at APD20, APD50, and APD90. C. Partial
blockade of Kv1 currents using 4-AP (100 uM) similarly prolonged action potential
durations in WT cardiomyocytes. **: p<0.01
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Figure 3.10 Non-repolarization indices of electrophysiological function. Nonrepolarization indexes of cardiomyocyte function in Kvβ2-/- cells, including A. dV/dtmax , B.
Resting membrane potential, and C. Action potential amplitude.
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Figure 3.11: Surface action potentials. Monophasic action potentials were
recorded from electrodes placed on the left ventricular epicardial surface of
Langendorff perfused hearts. Representative action potentials recorded from WT
(A) and Kvβ2-/- (B), overlayed (C). B. Action potential durations at APD20 (D),
APD50 (E), and APD90 (F) were significantly prolonged in Kvβ2-/- . n=5 mice WT
and 6 mice Kvβ2-/- *: p<0.05. Horizontal cale bar = 10ms. Vertical scale bar = 20
mV. These experiments were performed in collaboration with Dr. Srinivas Tipparaju
and Dr. Kalyan Chapalamadugu at the University of South Florida Department of
Pharmaceutical Sciences.
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Figure 3.12: Baseline cardiac function. Echocardiography was used to measure
stroke volume, ejection fraction and cardiac output. These functional values were similar
between WT and Kvβ2-/- mice.
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*

**

Figure 3.13: Cardiac anatomy. A. Heart weight normalized to tibia length in WT and Kvβ2/- mice. B. Left ventricular weight normalized to tibia length in WT and Kvβ2-/- animals. C.
Right ventricular mass was not reduced. D. Transverse sections of hearts were stained
with H&E stained transverse sections of hearts from WT and Kvβ2-/- animals. E. Hearts
excised from mice prior to dissection. **: p<0.001, *: p<0.01.
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Figure 3.14: Cardiac myocyte size in WT and Kvβ2-/- mice. A. Cardiomyocyte
length was measured under microscopy. B. Cardiomyocyte size was measured
using capacitance during voltage-clamp experiments. Over 50 cells from each
genotype were measured by both methods.
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CHAPTER IV
REGULATION OF CARDIAC Kv CURRENTS AND REPOLARIZATION BY
PYRIDINE NUCLEOTIDES

Introduction
Faced with a limited oxygen supply during ischemia, the oxidation of NADH
by the mitochondrial electron transport chain complexes is inhibited, causing a rise
in cytosolic NADH levels. As a ubiquitous electron shuttling cofactor, changes in
the NAD+/NADH ratio have widespread effects on the cell, including altering the
activity of various enzymes involved in intermediate metabolism. In the healthy
heart, the ratio of NAD+/NADH remain generally constant as they are constantly
recycled through various metabolic enzymes.

In the ischemic heart, this

equilibrium is disturbed by the lack of oxygen, and the reduced NAD + reserve is
reflected in the inhibition of various dehydrogenases involved in energy
metabolism.126 The accumulation of glycolytic byproducts NADH, lactate, and H +
may result in irreversible damage to the myocardium during ischemia.127
The redox status of the pyridine nucleotide bound to Kvβ is known to alter
the electrophysiological phenotype of the Kv channel complex (vide supra).
Nucleotides in the reduced state, NAD(P)H, allow the rapid inactivation of the Kv
channel by allowing free movement of the N-terminal inactivation domain of Kvβ1
and Kvβ3 containing complexes. Conversely, a bound nucleotide in the oxidized
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state, NAD(P)+, inhibits N-type inactivation by restraining the N-terminus of Kvβ1
and Kvβ3, preventing its access to the pore.82 Furthermore, in the presence of a
bound oxidized nucleotide, the hyperpolarizing effect of Kvβ2 on Kv1.5 is lost, and
the channel complex displays a V1/2-act not significantly different than that of Kv1.5
alone, an effect that is likely conserved for all Kv1.5-Kvβ interactions.79

We

therefore propose that Kvβ channel complexes may provide a mechanism linking
cardiac metabolism with repolarization, which may be of particular importance
during myocardial ischemia.
The Kvβ proteins are members of the aldo-keto reductase (AKR)
superfamily119,
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and are functional oxidoreductases that utilize pyridine

nucleotides, NAD[P](H), for the reduction of a wide range of carbonyl substrates.80,
129, 130

Accordingly, the Kvβ proteins bind pyridine nucleotides with high affinity,

with Kd values in the low micromolar range.76, 81
The redox status of the bound pyridine nucleotide confers profound electrophysiological effects on the Kvα-Kvβ channel complex (Figure 1.5). Studies in
heterologous expression systems have demonstrated that oxidized nucleotides,
NAD[P]+, prevent Kvβ1.3-mediated inactivation of Kv1.5.77 These studies have
been expanded to include other Kvα-Kvβ arrangments,78-80 further elucidating how
Kvβ-mediated modulation of Kv1 gating is dependent on the reduction state of the
bound pyridine nucleotide. The Kvβ2 protein product is shorter than Kvβ1 and
Kvβ3, lacking the N-terminal domain responsible for rapidly inactivating Kv1
channels.

NAD(P)+ has been shown to prevent the Kvβ2-mediated
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hyperpolarizing shift in Kv1.5 activation voltage79 and acceleration of Kv1.4
inactivation rate.80
We therefore designed experiments to test our hypothesis that the cytosolic
redox ratio of pyridine nucleotide affects cardiomyocyte excitability through the
modulation of outward Kv currents. We tested this using whole-cell voltage clamp,
perforated-patch current clamp, excised-patch single channel patch clamp
electrophysiology and Langendorff monophasic action potential recordings.

Results
Cardiac Kv current are differentially altered by pyridine nucleotide redox
ratios
In heterologous systems, the coexpression of Kv1 and Kvβ subunits
generate Kv currents whose inactivation rates are modulated by pyridine
nucleotides.54, 77, 80 To explore whether native cardiac Kv currents are sensitive to
such changes, ventricular cardiac myocytes were patched in whole-cell
configuration using pipette solutions chosen to represent normoxic and hypoxic
cytosolic conditions (Figure 4.1).

Upon reaching whole-cell configuration, series

resistance was compensated > 80% and pipette solution was allowed 5 min to
dialyze with the cytoplasm before running voltage clamp protocols.

Outward

currents were elicited with a +50 mV, 5 sec depolarization and fit triexponentially
offline. We found that the inactivation rate of Kv currents was significantly
accelerated under hypoxic compared to normoxic pipette conditions. The time
constants associated with the intermediately and slowly inactivating Kv currents,
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IK,slow1 and IK,slow2 were reduced in cardiac myocytes patched with hypoxic internal
solution than normoxic internal solution (Figure 4.1).

A comparison of all

calculated values is found in Table 2. Most notably, the intermediate tau value,
attributable to the cardiac current Ik, slow1, was reduced from 189 +/- 6 ms to 145
+/- 11 ms in myocytes patched with pipette solution containing high NADH (Figure
4.1). It has been previously proposed that the Ik,slow1 current is encoded by Kv1.5,
which above we demonstrate to associate with Kvβ2.

Langendorff perfusion with lactate increases cellular NADH concentration
and slows cardiac repolarization
We utilized a model developed by Dudley et al131 to manipulate cytosolic
NADH/NAD+ ratios. In these experiments, sodium lactate and sodium pyruvate
were added to the perfusion buffer to drive the lactate dehydrogenase reaction in
the desired direction (Scheme 4.1). In a preliminary experiment, hearts from both
WT and Kvβ2-/- were perfused with Tyrode’s buffer containing 20 mM lactate for
20 minutes and then frozen for measurement of cellular NADH content. It was
found that in both genotypes lactate perfusion significantly increased NADH levels
(Figure 4.2).
In electrophysiological experiments, Langendorff hearts were allowed to
beat spontaneously during perfusion and monophasic action potentials were
recorded from the left ventricular epicardial surface. It was found that action
potential durations were prolonged following 20 minutes of perfusion with lactate
20 mM as compared to each heart’s control values. Action potential duration was
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increased significantly at 20%, 50%, and 90% repolarization in WT hearts, p<0.05,
(Figure 4.3 A,B). Action potential durations were not different from control values
in Kvβ2-/- hearts (Figure 4.3 C, D). In a separate series of experiments, surface
action potentials were recorded from WT hearts perfused with 20 mM lactate for
20 min followed by 20 mM pyruvate for 20 min. In these experiments, pyruvate
perfusion caused APD90 to shorten toward their control values, presumably by
restoring intracellular NAD+ levels (Figure 4.4).

Action potentials recorded in perforated patch mode are prolonged by
lactate perfusion
We used current clamp to measure single cell action potentials in WT
cardiac myocytes perfused with 10 mM lactate in Tyrode’s perfusion buffer. The
perforated patch configuration using Amphotericin B (250 μg/ml) was utilized
because the pores formed by this perforating agent are sufficiently small to prevent
the passage of any molecule larger than monovalent ions. This allowed lactate to
drive an intracellular increase in NADH without it dialyzing out of the cell into the
pipette as it would in the whole-cell configuration. Action potentials were elicited
via small current injections of 0.8-1.0 nA lasting 2 ms at a frequency of 1 Hz. Action
potential durations following approximately 8 minutes of lactate superfusion were
normalized to control values in the same cell. We found that APD50 was
significantly increased during this treatment while APD20 and APD90 trended
toward prolongation as well (Figure 4.5 B). Action potential amplitude, resting
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membrane potential and upstroke velocity, dV/dt were not affected by the
treatment with lactate (Figure 4.5 C).

Single channel Kv activity was altered by perfusion with 1 mM NADH
To directly test the effect of NADH on Kv channel activity, single channel
activity was measured in inside-out patches pulled from freshly isolated cardiac
myocytes. Upon successfully obtaining an inside-out configuration, the membrane
patch was perfused for at least 4 minutes with a minimal buffer containing 140 mM
KCl, 10 mM HEPES and 1 mM HEDTA. Pipette internal solution was symmetrical.
The minimal composition of the buffer eliminated contamination with other cationic
currents.

Chloride channel activity was ruled out based on single channel

conductance values.

Patches were subjected to 4.5 s, +30 mV pulses at a

frequency of 0.05 Hz. Single channel activity was quantified as the percentage of
time the patch stayed in the open and closed states during each sweep. In one
representative experiment, the probability of the channel in the closed state
increased 10-fold upon addition of 1 mM NADH to the perfusate (Figure 4.6 A, B).
A marked increase in channel closure was seen almost immediately upon
perfusion of NADH (Figure 4.6 C).

Discussion
We have demonstrated by multiple electrophysiological modalities that
cardiac Kv conductance can be modulated by altering the pyridine nucleotide
redox status in the cardiac myocyte. There are multiple reports in the literature, by
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our group and others, who have clearly demonstrated a direct effect of pyridine
nucleotides on Kv channel activity in heterologous expression systems (vide
supra). To the best of our knowledge, the experiments herein described constitute
the first demonstration of endogenous Kv channel modulation by pyridine
nucleotides in a primary cell (cardiac myocyte) and tissue (the perfused heart).
In the classical biochemistry perspective, the pyridine nucleotides act as
electron carriers, supporting oxidation-reduction reactions involved in a variety of
anabolic and catabolic cellular processes. In addition to their role in support of
metabolic oxidoreductase reactions, new roles for these cofactors have emerged
with recent research. The pyridine nucleotides are now known to play roles in
regulation of cell signaling, gene transcriptional regulation, free radical production,
the thioredoxin and glutathione pathways and as ligands for ion channels.126, 128,
132, 133

In the case of ion channel modulation, pyridine nucleotide sensitivity,

particularly differential sensitivity for the oxidized (NAD[P]+) versus reduced
(NAD[P]H) states, has been proposed as a mechanism to link the metabolic status
of a cell to its excitability. When subjected to hypoxic or anoxic conditions, aerobic
metabolic capacity is diminished, resulting in an accumulation of the reduced
pyridine nucleotide NADH generated from glycolysis and the tricarboxylic acid
cycle. Without available oxygen, this NADH can not be oxidized back to NAD+
through the electron transport chain enzymes. This shift in pyridine nucleotide
redox putatively may serve as a metabolic queue to alter the conductances of
various ion channels, integrating metabolic activity with cellular excitability.
Multiple channels or channel subunits contain nucleotide binding domains which
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bind pyridine nucleotides with high affinity, including the calcium-activated K+
channels Slo1 and Slo2, KATP, the voltage-gated sodium channel Nav1.5, the cystic
fibrosis transport regulator CFTR, the lysosomal two-pore channel TPC2, the
transient receptor potential channel TRPM2, the ryanodine receptor RYR, and the
voltage-gated K+ channel subunit Kvβ proteins.
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These channels regulate many

distinct cellular processes involved in cellular metabolism and homeostasis, and
as such, their regulation by pyridine nucleotides may be a fundamental role of
these molecules outside of their electron carrying ability.
Whereas these nucleotides act as ligands to several structurally distinct ion
channels by poorly understood mechanisms (see APPENDIX), the understanding
of their molecular interaction with the Kvβ proteins is comparatively well delineated.
In an elegant set of experiments by Pan et al., 82 serial mutagenesis of residues in
the core domain and N-terminus of Kvβ1 was employed to determine the molecular
mechanism by which N-type inactivation is modulated by the redox state of the
pyridine nucleotide bound to Kvβ1. Mutants were coexpressed with the delayed
rectifier Kv1.1 in Xenopus oocytes and giant inside-out patches were pulled;
patches were depolarized to +60 mV from a -100 mV holding potential and %
inactivation (i.e. peak current – steady state current at 200 ms). Patches were
perfused with 4-cyanobenzaldehyde, previously described to be a reducible
substrate of the Kvβ proteins.78 Kvβ catalysis of 4-CY into 4-cyanobenzoic acid
requires the oxidation of the Kvβ-bound cofactor and thus this was utilized as a
model for assaying the residues involved pyridine nucleotide-dependent
modulation of N-type inactivation. These experiments provided the information
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implicating specific residues in the Kvβ1 core and N-terminal domains responsible
for restraining the inactivation domain when a reduced nucleotide is present in the
nucleotide binding domain.

Furthermore, these experiements mechanistically

linked the enzymatic turnover of substrate with rapid inactivation kinetics,
elucidating the processes by which both altered availability and redox status of
cytosolic nucleotides or the presence of an unknown carbonyl substrate may be
utilized to alter Kv channel conductances and thus cellular excitability. Thus, this
raises the interesting question of whether the primary mode of Kvβ-dependent Kv
channel modulation occurs through shifting cytosolic NAD(P)H/NAD(P)+ ratio or
through some unknown substrate to which Kvβ has a high turnover rate, or both.
Further experiments are being performed by our group as well as others to uncover
the physiological significance of these regulatory axes.
In this project, cardiac myocyte Kv conductances were altered by
intracellular dialysis of pipette mixtures containing either high NADH or NAD+
concentrations. Furthermore, modulation of intracellular pyridine nucleotide redox
status by lactate perfusion altered both cardiac myocyte and whole heart
repolarization rates. These are compelling evidences that pyridine nucleotides
have the ability to modulate cardiac repolarization, but further evidence is required
to demonstrate that they are endogenous regulators of ion transport or that
physiological or pathological changes in pyridine nucleotide levels have any effect
on ion transport. A more thorough understanding of these relationships may
require development of new modalities which are capable of simultaneously
measuring free nucleotide levels and ion channel conductances either in cells or
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tissue/organ preparations in order to delineate how these processes contribute to
in vivo.
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Figure 4.1: Cardiac Kv current inactivation.. Whole-cell outward Kv currents were
elicited in response to a 5s, +50 mV depolarizing pulse from a holding potential of -80 mV
and fit triexponentially. Current inactivation was accelerated under hypoxic pipette
conditions. Representative amplitude-normalized Kv currents (A). Inactivation time
constants for tau 2 (corresponding to Ik,slow1) and tau 3 (corresponding to Ik,slow2) were shorter
under hypoxic pipette mix conditions. . Pipette internal solutions contained either normoxic
(high NAD+) or hypoxic mixes (high NADH) of pyridine nucleotides. n= 19 cells (normoxic),
14 cells (hypoxic). (*: p<0.01, **: p<0.001.)
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Figure 4.2: Perfusion of hearts in Langendorff mode with lactate.
Hearts were perfused ex vivo with lactate 20 mM (Lactate +) for 20
minutes and flash frozen for later measurement of pyridine nucleotides.
Cellular NADH concentration increased significantly in both WT (top)
and Kvβ2-/- compared to controls perfused with standard Tyrode’s
buffer (Lactate -). n= 3 hearts WT and 3 hearts Kvβ2-/- for each
treatment.
*: p<0.05. These experiments were performed in
collaboration with Dr. Srinivas Tipparaju and Dr. Kalyan
Chapalamadugu at the University of South Florida Department of
Pharmaceutical Sciences.
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Figure 4.3: Lactate perfusion causes action potential prolongation in WT but not Kvβ2 -/hearts. Monophasic action potentials were recorded from Langendorff perfused hearts during
control (Lactate -) and following lactate 20 mM perfusion for 15 minutes (Lactate +). A. WT hearts
displayed prolonged action potential durations (APD). B. Action potential duration at 20, 50, and 90
% repolarization was increased. C. Kvβ2-/- repolarization was not sensitive to lactate. D. Action
potential durations in Kvβ2-/- were not changed from control. n=5 hearts WT and 5 hearts Kvβ2-/*:p<0.05. These experiments were performed in collaboration with Dr. Srinivas Tipparaju and Dr.
Kalyan Chapalamadugu at the University of South Florida Department of Pharmaceutical Sciences.
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Figure 4.4: Action potential prolongation caused by lactate is rescued by
perfusion with pyruvate. Monophasic action potentials were recorded on hearts as
they were perfused with control Tyrode’s (Lactate -) for 15 min, followed by 20 mM
lactate (Lactate +) for 20 minutes followed by 20 mM pyruvate (Pyruvate +) for 20
minutes. Pyruvate perfusion shortened APD90 back to control values. n=5 hearts. *:
p<0.05. These experiments were performed in collaboration with Dr. Srinivas Tipparaju
and Dr. Kalyan Chapalamadugu at the University of South Florida Department of
Pharmaceutical Sciences.
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Figure 4.5: Cardiac myocyte action potentials are prolonged by lactate
superfusion. Single cell action potentials were recorded in WT cardiac
myocytes (n=6) in the perforated patch configuration to allow intracellular
NADH accumulation during lactate perfusion. A. Representative traces
recorded during control (black) and following 8 min 10 mM lactate superfusion.
B. Action potential duration at 50% repolarization was significantly prolonged.
C. Action potential amplitude, resting membrane potential and upstroke
velocity was not different from control. n=6 cells. *: p<0.05.
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Figure 4.6: Single channel Kv activity in cardiac myocyte inside-out patches is
increased by NADH. A. Single channel activity was recorded from excised patches
pulled from cardiac myocytes perfused with control buffer. B. When 1 mM NADH was
added to the perfusate, single channel event activity increased approximately 10-fold
(percentage of time the channel spend in the closed state.) C. P(closed) was calculated
for each 5 second sweep during 4 minutes of control and 6 minutes of 1 mM NADH
perfusion.
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Scheme 4.1: Lactate dehydrogenase reaction. Langendorff-perfused hearts and
cardiomyocytes in perforated patch configuration were perfused with 10 mM or 20
mM sodium lactate in order to drive the LDH reaction to produce elevated cytoplasmic
NADH. Langendorff perfused hearts
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APPENDIX

OTHER ION CHANNELS MODULATED BY PYRIDINE NUCLEOTIDES128

Bacterial Potassium Transporters
It is currently believed that life originated in an aqueous environment in
which negatively charged biomolecules, such as proteins and nucleic acids, were
trapped in a semipermeable membrane. The high osmotic pressure exerted by
charged biomolecules was counterbalanced by a high concentration of positively
charged

K+ ions

within

the

membrane-delimited

cell.

This

intracellular

accumulation of K+ and exclusion of the more abundant seawater cation, Na+ was
probably used to energize the cell membrane. As a result, all living cells tightly
regulate K+ transport and use K+ as the major solute to control osmolarity. The
regulation of K+ transport is critically important not only for survival and growth but
also for maintaining cytosolic pH and for transmitting information from the
extracellular to the intracellular environment. Although it is unknown how archaic
cells regulated K+ transport, modern bacteria, such as Escherichia coli, maintain
separate systems for K+ uptake and efflux. Transport systems, such as Trk, Ktr,
and T2M channels, mediate active uptake of K+ ions, whereas K+ efflux is effected
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by the Kef system. Remarkably, all 4 of these transport systems possess a
nucleotide-binding potassium transport nucleotide–binding domain (KTNBD).134,
135

In uptake systems, this domain is in the cytosolic subunits (TrKA or KtrA) that

assemble with the membrane-spanning subunits (TrkG/H or KtrB/D), whereas in
systems mediating K+ efflux (KefC/B), the KTNBD is covalently linked to the
cytosolic C-terminus of the ion transporter. In both instances, the cytosolic location
of the NBD suggests a sensing mechanism in which ligand binding to the
intracellular domains of the transporter could alter K+ flux through the ionconducting pore. This possibility is reinforced by the invariant proximity of the
KTNBDs to the base of the innermost pore-forming helices134, suggesting that
conformational changes in the KTNBD could readily alter the ion transport
properties of the pore. The KTNBDs of bacteria form a well-conserved Rossmann
fold, which is a stable NAD+-binding motif composed of 6 parallel β strands linked
to 2 pairs of α-helices. This fold is commonly found in several bacterial and
eukaryotic dehydrogenases. The Rossmann fold of KtrA binds to both NAD + and
NADH. Binding of these ligands is essential for the maintenance of the tetrameric
state of KTNBD and ligand-mediated changes. This could impart conformational
changes in the ion-transporting subunit to alter its conducting properties, 134
although this has not been directly demonstrated.
Like KtrA, the K+ uptake proteins TrkG/H also interact with subunits (TrkA)
containing the KTNBD. The TrkA subunit of TrkG/H has 2 distinct dinucleotidebinding sites in each of 2 similar subdomains and, in addition to TrkG/H, TrkA also
interacts with several other proteins, such as TrkE, to form functional channels.
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Each half of the protein sequence of TrkA aligns with NAD +-dependent
dehydrogenases, such as lactate, malate, and alanine dehydrogenase, and
purified TrkA binds NAD+ and NADH with much higher affinity than ATP.136
Because TrkA lacks the C-terminal catalytic domain of dehydrogenases, it is
considered unlikely that the protein has enzyme activity. Nevertheless, it has been
proposed that binding of NAD(H) to TrkA regulates the transport activity of the
TrkG and the TrkH systems,134 but the functional regulation of Trk transporters by
NAD(H) has not been directly demonstrated to date. However, the presence of a
pyridine NBD in TrkA suggests potential coupling between energy expensive
import of K+ ions and active metabolism. This coupling might be particularly
important during cell growth. A high NADH:NAD+ ratio is a prerequisite for cell
growth, and activation of K+ import by pyridine nucleotides may be required to
maintain cytoplasmic K+ levels and turgor pressure during cell expansion.134
In contrast to the K+ uptake systems, which associate with nucleotidebinding proteins, the K+-efflux system, KefC, has a KTNBD that is covalently linked
to its ion-transporting subunits. The KefC transport system is inactivated by
reduced glutathione, and it is activated by glutathione-S-conjugates.137 Activation
of this transport by glutathione conjugates leads to acidification of the cytosol.
Because thiol reactivity is decreased at low pH, this might be a strategy for
preventing the modification of cytosolic protein thiols, and thereby for protecting
the bacteria from electrophilic stress. The C-terminal KTNBD of KefC is similar in
structure to the Rossmann fold of dihydrofolate reductase and it binds glutathione.
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Inhibition of KefC by glutathione is enhanced by NADH, but not NAD +, indicating
that NADH:NAD+ ratio could regulate the antiporter activity of KefC.138
In addition to glutathione and NADH, the KTNBD of KefC also binds to the
auxiliary subunits, KefF and KefG, which are required for the full activation of
KefB/C.139 The primary sequences of KefC and KefG show striking resemblance
to human quinone reductases and in the crystal structure of KefF, FMN is bound
to the KTNBD of the protein.140 Recently, it has been shown that the KefF is a
bonafide oxidoreductase in which NADH and NADPH act as electron donors and
quinones and ferricyanide act as acceptors.141 Although enzyme activity was not
found to be required for KefC activation, it was suggested that by catalyzing the
reduction of quinones, KefF protects KefC from the toxicity of electrophilic
quinones.141
As discussed, the link between K+ channels and nucleotide-binding proteins
in bacteria is conserved in eukaryotic K+ channels. Like the bacteria efflux systems
(Kef), some of the eukaryotic channels, such as the Slo channels, possess a
nucleotide-binding site in their cytosolic domain, whereas others, such as Kv
channels, associate with auxiliary subunits that bind pyridine nucleotides in a
manner reminiscent of the bacterial K+ uptake systems (Trk/Ktr). Moreover, like
bacterial channels, the mammalian K+ channels also are regulated by pyridine
nucleotides. It is likely that this mode of regulation is conserved during evolution
because it plays a critical, nonredundant role in linking K + transport to the
metabolic state of the cell, thereby enabling the cell to sense and respond to
changes in the external environment.
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Slo K+ Channels
The Slo family comprises high-to-intermediate conductance channels with
a C-terminal domain that bears close resemblance to TrkA and other NAD+-binding
prokaryotic K+ transporters.142 These channels are widely distributed across
Linnaean borders and are expressed in many types of cells, including cardiac
myocytes and smooth muscle cells. The 4 mammalian Slo genes, Slo1 (BKCa),
Slo2.1 (Slick), Slo2.2 (Slack), and Slo3, encode proteins that form K +-selective
homotetrameric channels.143 The core region of these channels resembles the
canonical Kv channels, but their cytoplasmic domain shows unusually high
structural diversity. Variations in the cytosolic domain enable these channels to
respond to a wide range of intracellular ions and metabolites. The cytosolic region
of Slo1 binds to calcium via the calcium bowl located at the distal end of its
hydrophilic tail; therefore, these channels are sensitive to changes in both
membrane potential and [Ca2+]i. The Slo2.1 channel is regulated by Cl−, but it
contains an ATP-binding domain as well. The Slo2.2 channel is insensitive to Cl−
and it does not bind ATP. Nevertheless, both Slo2 channels respond to elevated
[Na+]i levels, giving rise to the KNa current.144
Initial work showed that the KNa channels are sensitive to sodium only at
supraphysiological levels (50–80 mmol/L), making it doubtful whether they could
be regulated by physiological changes in [Na+]i that usually vary between 5 and 15
mmol/L.145 Channel run-down after initial excision also was frequently observed.
These discrepancies remained unresolved until Tamsett et al142 found that the
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cytoplasmic domain of both Slo2.1 and Slo2.2 contains NBDs similar to TrkA. This
site includes a canonical NAD+-binding βαβαβ motif that was required for
nucleotide binding. They also found that application of physiological levels of NAD+
to inside-out patches of rat dorsal root ganglion neurons led to a 2- to 2.5-fold
increase in the open probability of KNa channels and a decrease in EC50 of Na+
from 50 to 20 mmol/L. The specificity of this interaction was reinforced by the
finding that other cytosolic factors (cAMP, cGMP, and ATP) were without effect.146
NAD+, but not NADH, was effective in altering the gating properties of the channel,
but only in the presence of Na+. Moreover, like native KNa channels, the current
generated by Slack channels also was increased by NAD+ or NADP+. Site-directed
mutations at the NAD+-binding site of the Slo2 channel abolished this response,
suggesting that direct nucleotide binding to the cytosolic region of the channel is
required for these channels to respond to changes in pyridine nucleotide levels.
The regulation of KNa/Slo2 channels by NAD(P)+ suggests that the activity
of these channels may be coupled to the metabolic state of the cell. This mode of
regulation may be particularly important during ischemia–reperfusion and other
conditions in which accumulation of NAD(P)+ could increase K+ efflux via these
channels. High levels of intracellular NAD(P)+ also would increase the sensitivity
of these channels to intracellular sodium. Indeed, it has been suggested that in
ischemic cardiac myocytes, elevated [Na+]i levels activate KNa, and an increase in
this current shortens the action potential duration and induces calcium overload.147,
148

Therefore, regulation by pyridine nucleotides would allow these channels to

adapt simultaneously to both the metabolic and the ionic conditions prevalent in
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the ischemic heart. Interestingly, even though the evidence is indirect, it has been
proposed that the Slo2 channels are present in cardiac mitochondria.149 If present,
the regulation of these channels by pyridine nucleotides might represent
conservation of the link between metabolism and ion transport in modern
mitochondria and their prokaryotic ancestors.
The NAD+-binding site of Slo2 resembles the calcium binding site of the
cytoplasmic domain of Slo1 channels, which contain 2 regulators of potassium
conductance domains.143 The regulator of potassium conductance domain is
similar to the KTNBD of bacterial channels134

found in 6-transmembrane K+

channels, except that in the KTNBD the nucleotide binding Rossmann fold is not
conserved. The N-terminus of the regulator of potassium conductance domain of
Slo1 forms a Rossmann fold, which is similar to that seen in the structure of the
cytoplasmic region of Slo2.2150; however, amino acid replacements in this domain
during evolution have recruited the structure to bind calcium ions in case of Slo1
and sodium in case of Slo2.2. Although no direct pyridine nucleotide binding to the
regulator of potassium conductance domain of Slo1 channels has been
demonstrated, Lee et al151 have reported that application of 2 mmol/L NAD+ to the
internal face of excised patches from small (<300 μm) pulmonary arteries reduces
the open probability of BKCa channels, whereas NADH has the opposite effect.
However, pyridine nucleotides had no effect on steady-state BKCa conductance
in ear arterial smooth muscle cells151 or in large (>300 µm) intralobar pulmonary
arteries,152 although in large arteries, application of NADH did lead to a voltagedependent block of the channel.

Although these observations are intriguing,
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further studies are required to understand how intracellular changes in pyridine
nucleotides regulate the activity and the physiological role of Slo channels.

Kv2.1 Channels
Like members of the Kv1 and Kv4 family, the Kv2.1 channels also have
been shown to be sensitive to the redox ratio of pyridine nucleotides. MacDonald
et al153 have reported that in whole-cell recordings of Kv2.1 from pancreatic β-cells,
increasing the NADPH:NADP+ ratio in the patch pipette from 1:10 to 10:1
increased the contribution of fast inactivation to total inactivation from 40% to 60%.
The effects, however, were modest and could not be duplicated by Yoshida et al.154
Moreover, it is unclear how Kv2.1 is regulated by NADP(H). The Kv2.1 protein
does not associate with pyridine-binding subunit, such as Kvβ, and direct binding
of pyridine nucleotide to Kv2.1 has not been demonstrated. Although it is possible
that changes in NADPH/NADP+ levels could also affect Kv2.1 currents indirectly
by changing cell metabolism or kinase activation, there is no evidence to support
this possibility. Moreover, the physiological significance of the redox sensitivity of
Kv2.1 in insulin secretion is unclear, because it has been reported that changes in
Kv2.1 channels do not affect the levels of the critical pool of subplasma membrane
calcium that regulates exocytosis.155 Because NADPH facilitates insulin
exocytosis,156 it has been speculated that the binding of NADPH increases the
association of Kv2.1 with SNARE proteins, which facilitates granule docking or
priming.157 Although this is an interesting possibility, additional investigations are
required to fully elucidate the relationship between NADP(H) and Kv2.1 and to
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assess its importance in regulating insulin secretion or other physiological
phenomena.

Voltage-gated Sodium Channel
The voltage-gated sodium channel (Nav) conducts the fast inward sodium
current that gives rise to the upstroke of the action potential and regulates the
action potential duration. Therefore, small changes in sodium current profoundly
impact myocardial excitability and conductance and such changes attributable to
genetic mutations increase myocardial susceptibility to arrhythmias. Several gainof-function and loss-of-function mutations in the cardiac channel (SCN5A) and its
auxiliary subunits (Nav β1–β4 subunits) have been linked to arrhythmic
syndromes, such as the long Q-T (LQTS type 3), the Brugada, the sick sinus, and
the sudden infant death syndromes.158 In a large multigenerational family of Italian
descent with Brugada syndrome159 and in several cases of sudden infant death
syndrome,160 the pathogenic cause has been identified to mutations in the glycerol3-phosphate dehydrogenase-1-like protein (GPD1-L), which decrease surface
trafficking of SCN5A and the peak sodium current. The importance of GPD1-L is
further underscored by recent evidence showing that common variations in or near
GPD1-L are associated with increased risk of sudden cardiac death in patients
with coronary artery disease.161
GPD1-L is a 40-kDa protein that shares 84% sequence homology with
GPD, an oxidoreductase that converts dihydroxyacetone phosphate to glycerol-3phosphate. Because glycerol-3-phosphate is required for lipid synthesis, the
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activity of GPD connects carbohydrate metabolism to lipid synthesis. GPD also
contributes electrons to the mitochondrial electron transport system and maintains
the redox status of the pyridine nucleotide levels in the mitochondria by
participating in glycerol phosphate shuttle. GPD1-L displays glycerol phosphate
dehydrogenase activity, although its catalytic activity is slower than that of GPD.162,
163

Results of GST pull-down assays in a heterologous expression system suggest

that GPD1-L is directly or closely associated with the pore-forming α-subunit of
SCN5A.162 GPDL-1 mutations that have been linked to Brugada syndrome
(A280V) and sudden infant death syndrome (E83K) decrease GPDL-1 activity, but
do not alter its association with SCN5A.162 However, these mutations decrease
the surface expression of SCN5A, thereby reducing total INa.159,
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This

phenomenon is reminiscent of the behavior of Kvβ, which is also an
oxidoreductase that regulates the surface expression of its pore-forming partner
(Kv1). As seen with GPDL-1, loss-of-function mutations also decrease the effects
of Kvβ on Kv1 trafficking.164
The close association between Nav and GPD1-L suggests that the sodium
current may be sensitive to redox chemistry. Patch-clamp experiments of Dudley
et al165 show that in rat neonatal cardiac myocytes and in HEK cells expressing
SCN5A, intracellular dialysis with 20 to 100 μmol/L NADH directly inhibits and that
this is antagonized by incubating the cells with NAD+. This inhibition of INa was
linked to NADH-dependent protein kinase C (PKC) activation or mitochondrial
superoxide generation.165 However, the processes by which NADH could stimulate
PKC have not been identified and it was unclear how activated PKC could increase
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mitochondrial reactive oxygen species production. Moreover, NADH-mediated INa
suppression was not accompanied by changes in the inactivation of the channel
or the induction of window current or a late sodium current, usually seen in cardiac
myocytes exposed to oxidants.166-168 Valdivia et al
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suggest that at least some

of the effects of NADH on sodium current may be attributable to changes in GPD1L activity, because they were completely abolished by inhibiting PKC, indicating
that NADH has no direct effects on Nav. They link PKC activation to GPD1-L
activity, suggesting that NADH increased the production of glycerol-3-phosphate
by GPD1-L, which increases diacylglycerol formation. This increase in
diacylglycerol

stimulates

PKC

activity

and

results

in

greater

SCN5A

phosphorylation. Moreover, they found that PKC activation acutely decreases the
surface expression of SCN5A and this effect is prevented by the NADPH oxidase
inhibitor apocynin, suggesting that both channel phosphorylation and reactive
oxygen species production are required for PKC-mediated regulation of SCN5A
trafficking.162,

169_ENREF_153

However, these signaling pathways have been

delineated mostly in heterologous systems and, therefore, additional experiments
are required to determine endogenous regulation of I Na by pyridine nucleotide in
cardiac myocytes (or neurons) and to determine whether GPD1-L and pyridine
nucleotide–dependent changes in PKC activation and reactive oxygen species
generation affect only sodium channels or other ion transport mechanisms as well.

ATP-regulated K+ Channels
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The ATP-regulated K+ channels represent another class of K+ channels that
are regulated by nucleotides. Although these channels are primary regulated by
ATP, they also have been found to be sensitive to pyridine nucleotides as well.
The effects of pyridine nucleotides on the KATP channels were first described by
Dunne et al,170 who reported that in excised patches of insulin-secreting cells low
(100 μmol/L) concentrations of NAD(P)+ and NAD(P)H promoted channel opening,
whereas high concentrations (500 μmol/L) led to channel closure. These effects
were modified by ATP and ADP, indicating that pyridine coenzymes compete with
adenine nucleotides for the NBD of the channel.
The KATP currents are generated by a large conductance channel present
in the plasma membrane of several tissues, including the heart, smooth muscle,
and pancreatic β-cells.171, 172 An ATP-dependent potassium conductance has also
been identified in the mitochondria,173, 174 which has recently been found to be
attributable to a channel related to the ROMK (Kir1.1) channel of the renal outer
medulla.175

The sarcolemmal KATP channels open when the cellular

concentrations of ATP are low and are blocked at high ATP levels. These channels
are formed by the 4 pore-forming Kir6.2 subunits and 4 regulatory sulfonylurea
receptor (SUR2A) subunits. The current is inhibited by the binding of adenine
nucleotides to Kir6.2. Moreover, the NBD of SUR interacts specifically with Mg–
nucleotide complexes, resulting in channel opening.171 Therefore, in any given
metabolic state, the activity of the channel is a balance between the stimulatory
and inhibitory effects of adenine nucleotide binding. Experiments with Kir6.2/SUR1
expressed in Xenopus oocytes have shown that inhibition of these currents by
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NAD+ and NADP+ is mediated via binding to the Kir6.2 NBD, but not to the SUR1
NBD. The affinity of Kir6.2 for NADP(H) is markedly enhanced on interaction with
SUR1, perhaps because modification of the nucleotide-binding pocket of Kir6.2 by
SUR1

facilitates

the

attachment

of

mononucleotides, such as NADP(H).176

molecules

bulkier

than

adenine

Nevertheless, the physiological

significance of this interaction has not been assessed, and it is not clear whether
the cardiac SUR2A isoform responds similarly. Because pyridine nucleotides are
much less potent in inhibiting IKATP, it is likely that these nucleotides make only a
small contribution to inhibition of the channel. Moreover, because the Kir6.2
displays no specificity for oxidized or reduced species but responds only to bulk
nucleotide concentrations, it cannot participate in modulation of membrane
potential by the redox state of pyridine nucleotides. Additionally, the ability of low
concentrations of pyridine nucleotides to increase the activity of native K ATP
channels in pancreatic cells170 was not observed in oocytes expressing
Kir6.2/SUR1.176 Clearly, additional work is required to elucidate the mechanism of
binding of low levels of pyridine nucleotides and to assess the significance of
binding to physiological levels of NADP(H). Nevertheless, because pyridine
nucleotides levels change under conditions that affect ATP levels, it is likely that
native KATP channels are sensitive to both adenine and pyridine nucleotides.
Like the sarcolemmal KATP channel, the mitochondrial KATP currents also
respond to pyridine nucleotides. Measurements of mitochondrial K ATP activation by
osmotic swelling indicate that the channel activity could be inhibited by NADPH.177
The inhibition of the channel could not be related to reduction of mitochondrial
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thiols and, therefore, was ascribed to direct regulation of the channel activity by
NADPH. These observations suggest that the regulation of mitoKATP channels by
NADPH may be a physiological mechanism for sensing changes in energy
metabolism and the redox status of mitochondria, but extensive work will be
required to determine whether pyridine nucleotides are endogenous regulators of
mitochondrial K+ transport.

Cystic Fibrosis Transmembrane Conductance Regulator
The cystic fibrosis transmembrane conductance regulator is an ATPbinding cassette ion exchanger responsible for moving chloride and thiocyanate
ions across epithelial cell membranes. Mutations in this gene create a
nonfunctional protein that does not transport chloride and water in and out of cells
that line the lungs, the pancreas, the liver, and the reproductive and digestive
tracts. This disruption of osmotic gradients results in the production of abnormally
viscous mucous, causing the obstruction of the respiratory tract characteristic of
cystic fibrosis, as well as chronic dysfunction of other affected organs. The cystic
fibrosis transmembrane conductance regulator acts as a cAMP-activated ATPgated ion channel that allows Cl− ions to flow down their electrochemical gradient
and exit the cell. It has been reported that pyridine nucleotides can interact with
the NBD of cystic fibrosis transmembrane conductance regulator and that the
redox potential of pyridine nucleotides regulates the Cl− conductance of the
channel.178 It was found that when ATP levels were clamped, there was a marked
increase in Cl− conductance on dialysis of the cell with NADP+. In contrast, dialysis
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with NADPH inhibited Cl− conductance. Although these studies point to an
intriguing link between the redox state of pyridine nucleotides and Cl −
conductance, no studies seem to have followed-up on these initial findings.

Transient Receptor Potential (TRP) M2 Channel
Pyridine nucleotides and their metabolites also regulate calcium transport
and homeostasis. Although the effects of pyridine nucleotides on the voltagedependent calcium channels have not been reported, recent work has shown that
NAD+ regulates calcium homeostasis by modifying the activity of TRPM2 channel
(TRPM2). The transient receptor potential (TRP) M2 channel belongs to a large
TRP superfamily which comprises several 6 transmembrane cation channels
involved in a variety of processes ranging from sensation of touch, smell, taste,
pain, temperature, osmotic pressure, and apoptosis.179 A distinguishing feature of
the TRPM2 channel is the presence of a cytosolic nudix hydrolase domain in the
C-terminus of the channel that is highly homologous to the ADP pyrophosphatase
NUDT9 and is therefore named the NUDT9-homologous domain (NUDT9-H). The
NUDT9 domain of ADP pyrophosphatase displays 39% sequence identity with
TRPM2 and is a member of the Nudix family of proteins, such as 8-oxo-dGTP
hydrolase (MutT) and diadenosine tetraphosphate pyrophosphatase (AP4A
hydrolase).180 TRPM2 is highly abundant in the brain, but it is also expressed in
other tissues, including, spleen, liver, lung, heart, and myeloid cells.181

The

channel is nonselective for cations and displays a nearly linear current–voltage
relationship with a reversal potential near 0 mV.182 The physiological functions of
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TRPM2 have not been completely elucidated, but there is evidence showing that
the channel is involved in monocyte chemotaxis183, insulin secretion by pancreatic
β-cells184, and lysosomal calcium release.185

Studies with TRPM2-null mice

suggest that the channel controls the production of chemokines in monocytes and
the infiltration of neutrophils during inflammation.186 Because TRPM2 is highly
responsive to oxidative stress, it is likely that this channel could function as a redox
sensor187 by directly binding to NAD+ or its metabolite, ADPR.
Data from whole-cell patch-clamp experiments show that intracellular
dialysis with NAD+ 188 evokes a large inward current in cells expressing TRPM2
channels. In excised patches, application of NAD+ lead to instantaneous activation
of the channel, suggesting that NAD+ directly activates the channel without the
involvement of cytoplasmic or membrane components. However, regulation of the
channel by NAD+ remains controversial. Some investigators suggest that
stimulation of the channel by NAD+ may be attributable to contamination of the
commercially available NAD+ preparations that contain trace levels of ADPR,
which is the natural ligand of the channel.189 Nevertheless, direct binding of

32P-

NAD+ to a GST fusion protein of the C-terminal domain of TRPM2184, 187 suggests
that the channel protein interacts with NAD+, presumably as it does with ADPR.
Moreover, even though trace contamination by ADPR could account for the effects
of 1 mmol/L NAD+, channel activation at higher temperature also has been
observed at 300 μmol/L NAD+

184

and only minimal channel activation was

observed with 10 μmol/L ADPR188 (EC50 ≈100 μmol/L),182 suggesting that
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contamination with >10% ADPR would be required to fully account for pronounced
channel activation by commercial NAD+ preparations.
The binding of

32P-NAD+

to the C-terminus of TRPM2 channels indicates

that NAD+ interacts with ADPR binding site of the Nudix domain. The importance
of this domain has been confirmed by experiments showing that deletion of the Cterminus abolishes the activation of the channel by both ADPR and NAD+.187, 190
Hara et al187 have suggested that H2O2 activates TRPM2 by increasing the
intracellular NAD+, which precipitates cell death by inducing calcium and sodium
overload. A similar NAD+-activated conductance, reminiscent of the TRPM2
activity, also has been implicated in rat striatal neuron cell death induced by cell
depolarization and calcium influx.191 Additionally, it has been reported that a
similar NAD+-gated nonselective cation channel is activated in CRI-G1 rat
insulinoma cells treated with H2O2.192 The findings of these studies suggest that
stimulation of TRPM2 by NAD+ could activate cation influx and trigger cell death.
Similarly, in cardiac myocytes, activation of TRPM2 and the resultant sodium and
calcium overload have been proposed to be obligatory steps in H2O2-mediated
apoptosis.124 Nonetheless, it remains unclear whether myocardial oxidative injury
in vivo during ischemia–reperfusion could be attributed to TRPM2 activation and
whether this is mediated by NAD+ binding to the channel. Further experiments with
TRPM2-null mice are warranted to rigorously delineate the role of TRPM2 in
myocardial ischemic injury and heart failure and to determine whether the activity
of the myocardial channel is regulated by NAD+.
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In addition to its direct effects on the channel, NAD+ could affect the
regulation of TRPM2 by its endogenous ligand, ADPR, or inhibit the catalytic
activity of the C-terminal domain of the channel. It is currently believed that TRPM2
is activated by ADPR generated from the cleavage of NAD+ by CD38.193 Thus,
NAD+ levels could indirectly affect TRPM2 activity by regulating the supply of
ADPR. NAD+ also could compete with ADPR binding and catalysis. The NUDT9
domain of the channel has low levels of ADPR pyrophosphatase activity182 which
could be inhibited by NAD+ and other pyridine nucleotides and their metabolites,
although this possibility has not been directly tested. Regardless, the presence of
a catalytic domain within the channel is fascinating because it indicates that as
seen with the bacterial Kef system, the TRPM2 channels belong to a distinct class
of channel proteins that possess catalytic activity. Even though the enzymatic
activity of NUDT9 is considerably lower than in the ADPR pyrophosphatases, this
may be an evolutionary adaptation to increase the dwell time of ADPR at the
channel.190 Moreover, mutations of the catalytic domain that increase enzymatic
activity of NUDT9-H decreased channel activity, suggesting that nucleotide
binding, not catalysis, activates the channel. Notably, the interesting possibility that
channel gating or ion flow modulates the catalytic activity of NUDT9-H has not
been tested.

Ryanodine Receptor (RyR) Calcium Release Channel
The RyRs represent another class of ion channels that may be regulated by
pyridine nucleotides. Sequence analysis and homology modeling studies show
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that the RyR of the skeletal muscle (RyR1) contains several dehydrogenase and
NAD+/NADH oxidoreductase domains.194 This region is located near the Nterminus of the RyR1 and it shows significant structural homology to isocitrate
dehydrogenase and isopropylmalate dehydrogenase. It also contains additional
motifs related to the alcohol dehydrogenase. Notably, several of the residues that
participate in NADP+ binding in isocitrate dehydrogenase are conserved in RyR1,
suggesting that the channel may be capable of binding to pyridine nucleotides.
Indeed, equilibrium-binding studies indicate low-affinity binding of [3H] NAD+ to the
sarcoplasmic reticulum membrane (Kd=10 μmol/L), although kinetic studies
indicate a much higher affinity (Kd=50 nmol/L). On the basis of these studies, it
has been estimated that nearly 10 molecules of NAD + bind to each subunit of
RyR1.194 Sequence alignment demonstrates that the the cardiac RyR2 protein
shares ≈82% homology with RyR1 between amino acids 41 and 1200, and that
this region of the protein contains multiple nucleotide-binding sites with significant
structural and sequence homology to phosphorylated isocitrate dehydrogenase.
The same region also encompasses both catalytic and binding sequences
common to dehydrogenases and oxidoreductases.
The results of structural and biochemical studies are consistent with
functional measurements. In permeabilized ventricular myocytes, addition of
NADH decreases the frequency of calcium sparks,195 and this inhibitory effect of
NADH is partially reversed by NAD+, although NAD+ by itself has no effect on
calcium spark frequency. These findings suggest that an increase in NADH/NAD +
(eg, during ischemia) could inhibit spontaneous sarcoplasmic reticulum calcium
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release. Nevertheless, the biochemical basis and the physiological significance of
these findings are yet to be established. Particularly, it is unclear whether these
effects are because of direct binding of NAD+ to RyR or because of some other
indirect NAD+-dependent changes, such as increased superoxide generation by
NADH oxidase.196
Although NAD+ does not activate calcium sparks in permeabilized
myocytes, addition of 1 µmol/L NAD+ increases the open probability of single RyR2
cardiac calcium release channels incorporated into planar phospholipid bilayers.197
A similar increase has been reported for skeletal muscle RyR1 channels; in which
case, addition of 1 to 10 μmol/L NAD+ led to a 7- to 80-fold increase in open
probability.198 These observations suggest that NAD+ can directly activate calcium
release channels; however, additional investigations are required to fully assess
the role of pyridine nucleotides in regulating the calcium release channels, to
determine whether the oxidoreductase domains of the RyR are catalytically active,
and whether this catalysis regulates calcium release by the channel.

Regulation of Calcium Signaling by NAADP+
In addition to directly regulating ion transport, pyridine nucleotides also generate
specialized metabolites that regulate cell signaling, particularly calcium fluxes. The
most potent of these metabolites is nicotinic acid adenine dinucleotide phosphate
(NAADP+), which stimulates calcium release in different cell types at
concentrations as low as 5 to 10 nmol/L. Activation of calcium release by NAADP +
has been found to regulate several physiological processes, including fertilization,
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neurite outgrowth, synaptic function,199 and insulin secretion.200 NAADP+ also
mobilizes calcium stores in smooth muscle cells201 and cardiac myocytes.202 In
endothelial cells, NAADP+ has been recognized as an essential mediator of
histamine-induced secretion of von Willebrand factor203 and a regulator of nitric
oxide production.204

On the basis of the observation that intravenous

administration of a cell permanent NAADP-ester lowers blood pressure in rats, it
has been suggested that NAADP+ regulates systemic blood pressure.204
NAADP+ is an NADP+ derivative in which the nicotinamide ring is replaced
by nictonic acid. This structural difference may be sufficient in preventing NAADP+
binding to most NADP+-binding proteins, and in promoting specific recognition of
NAADP+ by its cognate receptors. The biochemical processes involved in NAADP+
synthesis have not been completely identified. In vitro NAADP+ is synthesized from
NADP+ by both ADP-ribosyl cyclases and CD38,205 but it is not clear whether these
enzymes synthesize NAADP+ in vivo. Measurements of basal NAADP+ levels in
several tissues show that CD38-null mice maintain normal NAADP+ levels.206
Moreover, increases in NAADP+ levels in histamine-stimulated myometrial cells206
and in glucose-stimulated islet cells200 are preserved in the absence of CD38,
although NAADP+ generation in response to CCK stimulation in pancreatic acinar
cells207 is attenuated. Thus, at least in some cells, NAADP+ synthesis seems to be
CD38-independent and it is likely that there are additional enzyme(s) involved in
generating basal and agonist-evoked NAADP+.
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Agonist-stimulated increase in NAADP+ levels is associated with release of
calcium from intracellular stores that are different from those mobilized by IP3 or
cyclic ADPR.208 It is currently believed that NAADP+ targets lysosome-related
stores as some of its effects are inhibited by depletion of acidic calcium stores, but
not by inhibitors of sarco/plasmic or endoplasmic reticulum Ca 2+-ATPase. The
ability of NAADP+ to release calcium from lysosomes has been related to the
activation of 2-pore channels (TPCs).209, 210 These channels contain 2 putative
pore-forming repeats and their transmembrane regions are similar to that of other
channels, such as the Nav or TRP channels however, instead of the plasma
membrane, these channels are located in the endolysosomes and lysosomes or
the ER. To date, 3 genes encoding TPCs (TPCN1-3) have been identified, of which
TPCN2 is the predominant form expressed in primates and humans. Cells
expressing TPC2 show a marked increase in calcium release on intracellular
dialysis with 10 nmol/L NAADP+. Conversely, genetic knockdown of these
channels abolishes NAADP+-induced calcium release, indicating that TPCs are
endogenous targets of NAADP+.208 However, in addition to TPCs, NAADP+ also
activates RyR211 and TRP subtype mucolipin 1 (TRP-ML1)212 and, at high
concentrations, the TRPM2213 channels. The role of each of these channels in
shaping the overall calcium response to NAADP+ is not clear, but it has been
suggested that responses of multiple NAADP+ targets are integrated such that the
small localized release of calcium by NAADP+ via TPCs is amplified by neighboring
receptors to generate well-orchestrated calcium oscillations.
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The molecular mechanisms by which NAADP+ regulates TPCs remain to be fully
elucidated. Data from HEK-293 cells show that relative to wild-type cells, cells
stably overexpressing TPC2 display increased [32P] NAADP+ binding at highaffinity (Kd=5 nmol/L) and low-affinity (Kd=10 μmol/L) sites.210 However, the results
of photoaffinity studies using radioactive 5-azido NAADP+ show no direct binding
to the TPC protein. These studies, however, did show that some unknown lowmolecular-weight proteins were labeled by [32P] NAADP+ and that the labeling of
these proteins was preserved in TPC-null cells.214 These observations suggest that
similar to what has been observed with other pyridine coenzyme–regulated
channels (eg, Kv channels), there might be ancillary proteins within the larger TPC
complex, which impart NAADP+ sensitivity to TPCs.

Because NAADP+ is synthesized from NADP+, it is possible that this synthesis is
sensitive to prevailing intracellular levels of pyridine nucleotide as well as cellular
redox state. However, CD38-ribose and ADP-ribose cyclase-dependent NAADP+
synthesis requires nicotinic acid, which binds to these enzyme with low affinity (half
maximal effective concentration, 5 mmol/L).205 Therefore, under most conditions,
the availability of nicotinic acid, rather than NADP+, is likely to be the limiting factor.
NAADP+ signaling could, however, be coupled to the cellular redox state by
enzymatic reduction of NAADP+ to NAADPH. NAADP+ is structurally related to
NADP+ and it binds to NADP+-linked enzymes, such as glucose-6-phosphate
dehydrogenase and 6-phospho gluconate dehydrogenase.215 The reduction of
NAADP+ by glucose-6-phosphate dehydrogenase generates NAADPH, which
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does not induce calcium release. Hence, it is possible that enzymatic reduction is
an off signal that limits the actions of NAADP+, and that this reductive process
couples NAADP+ signaling to the overall redox state of the cell. In this regard, it is
interesting to point out that several processes that involve NAADP + signaling, for
example, fertilization,216 are also associated with dramatic changes in the redox
state; therefore, the redox sensitivity of NAADP+ may be the missing link between
calcium-mediated signaling and cell metabolism.

Summary and Perspective
In classical biochemistry, pyridine nucleotides are most frequently viewed
as soluble electron carriers. As coenzymes, they are known to support oxidation–
reduction reactions and to control cell metabolism. However, recent research
suggests that pyridine nucleotides can also regulate cell signaling, gene
transcription, and ion transport by acting as electron donors, enzyme substrates,
or ligands of specific receptors. Unlike most signaling molecules, pyridine
nucleotides also impart redox sensitivity to regulatory processes. By doing so,
these nucleotides control a large network of reactions, and therefore they can
effectively integrate metabolism, cell signaling, gene transcription, proliferation,
and cell death. Many of these processes depend on ion transport and homeostasis
and, thus, the ability to regulate ion channels may be a fundamental feature of the
biological role of pyridine nucleotides.
Although research in this area is still maturing, several ion-transporting
proteins have been shown to either contain NBD motifs or assemble with auxiliary
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subunits that bind pyridine nucleotides. The association between nucleotides and
ion transport has been conserved during evolution, and NBD-containing ion
transport systems have been found in organisms ranging from bacterium to
human. Although during evolution, some of these domains have been recruited to
provide structural stability to proteins or to bind other ligands, most are still capable
of high-affinity pyridine nucleotide binding. In addition, recent studies have shown
that some NBD motifs of ion transport proteins are functional and that the activity
of several ion transporters is modified by exogenous addition of pyridine
nucleotides. There is also evidence to suggest that pyridine nucleotides regulate
ion fluxes by binding directly to ion transport proteins or their ancillary subunits.
Yet, there is little direct evidence showing that pyridine nucleotides are
endogenous regulators of ion transport or that physiological or pathological
changes in pyridine nucleotide levels have any significant effect on ion transport.
Additional research therefore is needed to establish cause-and-effect relationships
between pyridine nucleotides and ion transport. To delineate these relationships,
it may be necessary to develop new methods for simultaneously measuring free
nucleotide levels and ion transport in living cells and to determine how pyridine
nucleotides regulate ion transport in vivo.
As

discussed,

recent

research

has

uncovered

several

potential

mechanisms by which pyridine nucleotides can regulate ion fluxes. In bacterial K +
transporters, such as KtrA, for example, nucleotide binding induces specific
changes in channel conformation—changes that could possibly alter the ionconducting properties of the channel pore.134 Similarly, in eukaryotic channels,
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such as the Slo K+ channels, the binding of pyridine nucleotides to the cytosolic
domain of the channel alters channel gating, whereas in Kv1 complex nucleotide
binding to Kvβ affects inactivation of the current. In addition, as shown for Kv1164
and SCN5A162 channels, NBD proteins could also facilitate channel trafficking and
localization. Moreover, as in the bacterial KefC channels, catalytically active NBD
proteins could help protect channel proteins from oxidative injury. Such proteins
could also provide the channel privileged access to metabolites that regulate
channel activity—as in case of the Nav-associated protein GPD1-L, which
regulates selective PKC phosphorylation of the channel. Although the general
applicability of this function is unclear, other channel proteins, like Kvβ, are also
constitutively associated with PKC,72 suggesting that association with other
signaling proteins may be required to support local channel-specific regulation. In
most cases described in the literature, however, the speculated roles of pyridine
nucleotides in regulating ion fluxes remain unsubstantiated. Additional research is
required to delineate the specific roles of pyridine nucleotides and their metabolites
in the regulation of channel activity, localization, and posttranslational modification.
Additional research also is required to evaluate the physiological and the
pathological implications of this regulatory axis. For instance, even though
circumstantial evidence suggests that pyridine nucleotides play an important role
in the regulation of HPV, insulin secretion, oxygen sensing, or even circadian
rhythms,217 there is no clear evidence to actually implicate pyridine nucleotides in
these phenomena. It is similarly unclear whether the ischemic dysfunction of
myocardial ion conductances is related to changes in pyridine nucleotide signaling.
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Finally, the exciting possibility that, in addition to being regulated by NBD proteins,
ion transport proteins in turn can regulate the activity of pyridine nucleotide–
dependent proteins has yet to be tested. As mentioned, several channelassociated proteins, such as KefF, Kvβ, GPD1-L, and NUDT9-H, are catalytically
active; therefore, changes in membrane potential could affect the activities of these
enzymes. Further exploration of this possibility could reveal new mechanisms by
which membrane potential regulates cell chemistry and metabolism. In the brain,
such processes might be the basic molecular units of memory and learning; in nonneuronal cells, this mechanism could, perhaps, impart metabolic memory or
contribute to the epigenetic regulation of gene expression. To understand these
and other complex relationships between ion transport and pyridine nucleotides,
however, we would first need to identify and characterize specific components of
the individual ions channels that are regulated by pyridine nucleotides. From these
findings, we would have to develop an integrated systemwide view—a view that
would detail how exactly different ion transport mechanisms are synchronously
regulated to support basic cell function or to mount a well-orchestrated unified
response to environmental cues. Thus, further elucidation of this link between
pyridine nucleotides and ion transport might provide a new understanding of the
mechanisms underlying several physiological processes and disease states.

141

CURRICULUM VITAE
Peter J. Kilfoil
University of Louisville, School of Medicine
Institute of Molecular Cardiology
580 S Preston St
Louisville, KY 40202
Preferred Phone: 720-985-4372
pjkilf01@louisville.edu
citizenship: United States
Education
Graduate – University of Louisville School of Medicine, Louisville, KY
Biochemistry and Molecular Genetics
Advisor: Dr. Aruni Bhatnagar
08/2011-present
M.S., 04/2014
Ph.D., April 2016, GPA 4.0
Dissertation: MODULATION OF CARDIAC Kv CURRENTS BY Kvβ2 AND
PYRIDINE NUCLEOTIDES
Graduate - University of Kentucky, Lexington, KY
Biomedical Engineering
08/2003 - 8/2005
M.S., 2007, GPA 3.91
Undergraduate – Vanderbilt University, Nashville, TN
Biomedical Engineering
08/1997 - 05/2001
B.E., 2001, GPA 3.20

Summary of expertise and research experience
My overall career goal is to identify mechanisms responsible for
arrhythmogenesis and to further understanding of cardiac electrophysiology. To
date, my research has focused on how subunits of the voltage-gated K+ channels
modulate the repolarization phase of the cardiac action potential. Utilizing mice
lacking genes for the Kvβ1 and Kvβ2 proteins, I have examined the physiological
142

roles of these subunits with an approach utilizing patch-clamp electrophysiology,
biotelemetry, immunofluorescence, confocal microscopy, intracardiac pacing and
molecular biology techniques. Using these approaches, I have uncovered a
cardiac phenotype in mice lacking Kvβ2. I have also spearheaded a side project
in which I am investigating a role of the same protein in pancreatic islet
excitation-secretion coupling and glucose homeostasis. While the above projects
described are mine, I also have a track record of successful collaboration,
contributing my electrophysiological expertise to other projects in our center.
Recently, I collaborated on a project in which I examined the effects of a reactive
aldehyde on voltage-gated sodium currents in isolated cardiomyocytes. As a
whole, I believe this training has prepared me well to identify and investigate
various cardiac pathologies as a postdoctoral researcher and ultimately an
independent investigator.

08/2010 - current
University of Louisville, Dept. of Molecular Cardiology
Examining the role of voltage-gated ion channels in cardiomyocyte
electrophysiology. .
08/2010 – current
University of Louisville, Diabetes and Obesity Research Center
Examining the role of voltage-gated potassium channel subunit Kvβ2 in
pancreatic β-cell repolarization and insulin secretion.
0/2003- 08/2005
University of Kentucky, Wenner Gren Center for Biomedical Engineering
In completion of Masters’ degree, investigated the effects of endurance training
on lower-limb vascular properties as pertaining to orthostatic hypotension
following spaceflight. Research techniques used include: ECG analysis, human
instrumentation, signal processing, MATLAB coding and analysis.
Publications
Kilfoil PJ, Chapalamadugu KC, Raucci FJ, Tur J, Brittian KR, BrittBhatnagar A,
Tipparaju SM. The ancillary subunit Kvβ2 alters Kv1 trafficking and modulates
the electrophysiological properties of ventricular cardiac myocytes. Manuscript in
preparation
Kilfoil PJ, Barski OA, Bhatnagar A. Modulation of Pancreatic Islet
Electrophysiology and Insulin Release by Potassium Channel Subunit Kvbeta2.
Manuscript in preparation
Dassanayaka S, Brainard RE, Watson LJ, Long BW, Brittian KR, DeMartino AM,
Aird AL, Kilfoil PJ, Muthusamy S, Hamid T, Prabhu SD, and Jones SP.
Cardiomyocyte Ogt limits ventricular

143

dysfunction in mice following pressure overload without affecting hypertrophy. In
submission, AJP Heart and Circ Phys
Tur J, Chapalamadugu KC, Padawer T, Badole SL, Kilfoil PJ, Bhatnagar A,
Tipparaju SM. Deletion of Kvβ1.1 subunit leads to electrical and haemodynamic
changes causing cardiac hypertrophy in female murine hearts. Exp Physiol.
2016 Apr 1;101(4):494-508.
Conklin DJ, Guo Y, Jagatheesan G, Kilfoil PJ, Haberzettl P, Hill BJ, Baba SP,
Guo L, Wetzelberger K, Obal D, Rokosh DG, Prough RP, Prabhu SD,
Velayutham M, Zweier JL, Hoetker D, Riggs DW, Srivastava S, Bolli R, and
Bhatnagar A. Genetic Deficiency of Glutathione S-Transferase P Increases
Myocardial Sensitivity to Ischemia-Reperfusion Injury. Circulation Research.
2015 Aug 14; 117(5):437-49.
Kilfoil PJ, Tipparaju SM, Barski OA, and Bhatnagar A. Regulation of Ion
Channels by Pyridine Nucleotides. Circulation Research 2013 Feb
15;112(4):721-41.
Tipparaju SM, Li XP, Kilfoil PJ, Xue B, Uversky VN, Bhatnagar A, Barski OA.
Interactions between the C-terminus of Kv1.5 and Kvβ regulate pyridine
nucleotide-dependent changes in channel gating. Pflugers Archive
2012;463:799-818.
Wang R, Lacour-Gayet FG, Lanning CJ, Rech BA, Kilfoil PJ, Hertzberg J,
Shandas R. Initial experience with the development and numerical and in vitro
studies of a novel low-pressure artificial right ventricle for pediatric Fontan
patients. ASAIO J. 2006 Nov-Dec;52(6):682-92.
Presentations and Abstracts
Kilfoil PJ, Barski OA, Bhatnagar A. Modulation of Pancreatic Islet
Electrophysiology and Insulin Release by Potassium Channel Subunit Kvbeta2.
Biophysical Journal, vol. 108, issue 2, p. 278a
Panguluri SK, Kilfoil PJ, Chapalamadugu KC, Tur J, Bhatnagar A, Tipparaju SM.
Genetic Ablation of Voltage-Gated Potassium Channel Beta-subunit 2 Causes
Distinct Physiological and Cardiac Alterations in Mice. Circulation.
2013;128:A18907
Kilfoil PJ, Barski OA, Brittain K, Prabhu SD, Bhatnagar A, Tipparaju SM.
Genetic Ablation of Potassium Channel Subunit Kvβ2 Slows Repolarization in the
Cardiac Septum and Leads to Cardiac Remodeling. Circulation. 2011; 124:
A14194

144

Kilfoil PJ, Barski OA, Brittain KR, Prabhu SD, Bhatnagar A, Tipparaju SM.
Physiological characteristics of mouse with genetic ablation of Kvbeta2. Gordon
Research Conference-Ion Channels. July 2010, Tilton, NH.
Evans JM, Kilfoil PJ, Wang S, Mohney L, Knapp CJ. Cardiovascular Responses
to Standing and Walking in Earth and Simulated Moon and Mars Gravities.
FASEB J. April 2010 24 (Meeting Abstract Supplement) 616.1
Wang S, Randall DC, Knapp CF, Nelson KR, Patwardhan AR, Kilfoil PJ, Evans
JM. Autonomic regulation in patients with diabetic neuropathy. FASEB J. April
2010 24 (Meeting Abstract Supplement) 1020.14
Wang S, Randall DC, Knapp CF, Patwadhan A, Kilfoil PJ, Evans JM.
Dysfunction of Autonomic Regulation of Short Term Blood Pressure in Diabetes.
Gill Heart Institute Annual Conference. Lexington, KY 2009
Kilfoil PJ. Gender Differences in Artificial Gravity Training. Biomedical
Engineering Society National Conference, Philadelphia, PA 2005
Kilfoil PJ. Active and Passive Artificial Gravity Training Results. Gill Heart
Institute Annual Conference. Lexington, KY 2004

Technical Expertise:
 Patch clamp electrophysiology (whole cell, perforated patch, single
channel)
 Voltage clamp and action potential recording
 Adult mouse cardiomyocyte isolation
 Adult mouse pancreatic islet isolation
 Confocal microscopy
 ECG telemetry implantation and analysis
 Protein isolation and Western blot analysis
 mRNA isolation and quantitative rt-PCR
 Coimmunoprecipitation
 Cell culture
 Technical training of students and postdocs
 Review of manuscripts for Toxicology and Applied Pharmacology
 Assisted in review of manuscripts for Circulation Research

Professional Societies
American Heart Association, Council for Basic Cardiovascular Sciences
Biophysical Society
Kentucky Academy of Sciences
The Society for Experimental Biology
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